Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	microtubule motor activity	STARD9 KIFC1 DNAH10 DNAH7 DNAH17 KIF4B KIF13A	2.03e-05	70	239	7	GO:0003777
GeneOntologyMolecularFunction	acetylation-dependent protein binding	KMT2A TAF1 BAZ2A BRD7 EP300	3.10e-05	31	239	5	GO:0140033
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYH11 STARD9 KIFC1 DNAH10 DNAH7 DNAH17 KIF4B KIF13A	8.84e-05	118	239	8	GO:0003774
GeneOntologyMolecularFunction	microtubule binding	MAP1B TTBK2 EML5 STARD9 CCSER2 KIFC1 EZR MID2 APC CCDC187 KIF4B FHDC1 KIF13A	9.26e-05	308	239	13	GO:0008017
GeneOntologyMolecularFunction	transcription factor binding	BDP1 HIF1A DTX3L TRIM11 FBP1 KMT2A MMS19 CHD6 TAF1 BSN HSF1 FOXO1 RARG PHF12 PCLO E4F1 MED1 TGFB1I1 BAZ2A BRD7 EP300 CRTC2	1.11e-04	753	239	22	GO:0008134
GeneOntologyMolecularFunction	transcription coregulator binding	HIF1A CHD6 BSN FOXO1 PHF12 PCLO MED1 EP300	2.88e-04	140	239	8	GO:0001221
GeneOntologyMolecularFunction	histone acetyltransferase binding	KANSL1L GLI3 MED1 MTF1	3.76e-04	29	239	4	GO:0035035
GeneOntologyMolecularFunction	lysine-acetylated histone binding	KMT2A TAF1 BAZ2A BRD7	4.29e-04	30	239	4	GO:0070577
GeneOntologyMolecularFunction	STAT family protein binding	DTX3L HSF1 EP300	4.43e-04	13	239	3	GO:0097677
GeneOntologyMolecularFunction	tubulin binding	MAP1B TTBK2 EML5 STARD9 CCSER2 KIFC1 EZR MID2 APC CCDC187 UNC5C KIF4B FHDC1 KIF13A	6.84e-04	428	239	14	GO:0015631
GeneOntologyBiologicalProcess	regulation of protein localization to early endosome	DTX3L EZR RDX MSN	3.38e-06	10	237	4	GO:1902965
GeneOntologyBiologicalProcess	positive regulation of protein localization to early endosome	DTX3L EZR RDX MSN	3.38e-06	10	237	4	GO:1902966
GeneOntologyBiologicalProcess	positive regulation of protein catabolic process	PABIR1 CREBRF FBXW8 TAF1 SGSM3 FOXO1 EZR NRDC APC RDX MSN PPP2R3A	1.39e-05	228	237	12	GO:0045732
GeneOntologyBiologicalProcess	positive regulation of protein localization to endosome	DTX3L EZR RDX MSN	1.55e-05	14	237	4	GO:1905668
GeneOntologyBiologicalProcess	regulation of protein localization to endosome	DTX3L EZR RDX MSN	2.10e-05	15	237	4	GO:1905666
GeneOntologyBiologicalProcess	positive regulation of catabolic process	PABIR1 HIF1A TICAM1 DTX3L SESN1 CREBRF FBXW8 TRIM11 TAF1 SGSM3 HSF1 FOXO1 EZR NRDC MID2 APC RDX MSN TGFB1I1 PPP2R3A GPSM1 CAPRIN1	2.11e-05	701	237	22	GO:0009896
GeneOntologyBiologicalProcess	protein localization to early endosome	DTX3L EZR RDX MSN	2.77e-05	16	237	4	GO:1902946
GeneOntologyBiologicalProcess	organelle assembly	CYLD HIF1A MYH11 CENPC ASAP1 TTBK2 FBXW8 ATXN2 STARD9 CLTC SGSM3 HSF1 KIFC1 EZR VPS37A SYNE1 RDX STAM DNAH7 MSN CEP63 TBC1D31 HAUS1 DNAH17 KIF4B WEE2 FHDC1 CAPRIN1 EP300	4.97e-05	1138	237	29	GO:0070925
GeneOntologyBiologicalProcess	cell cycle process	PABIR1 CENPC C9orf78 DTX3L HORMAD1 RINT1 STARD9 TIPIN RECQL5 CLTC CCNA1 TIMELESS MMS19 TAF1 HSF1 ZNF541 KIFC1 EZR APC RDX E4F1 MED1 CEP63 PPP2R1A HAUS1 BRD7 TAS1R2 ANKRD17 KIF4B WEE2 CKAP2 EIF4G3 KIF13A GPSM1	5.04e-05	1441	237	34	GO:0022402
GeneOntologyBiologicalProcess	positive regulation of stress granule assembly	HIF1A HSF1 CAPRIN1	8.04e-05	8	237	3	GO:0062029
GeneOntologyBiologicalProcess	regulation of organelle assembly	CYLD HIF1A ASAP1 TTBK2 SGSM3 HSF1 EZR SYNE1 RDX STAM MSN CAPRIN1	1.02e-04	280	237	12	GO:1902115
GeneOntologyBiologicalProcess	positive regulation of early endosome to late endosome transport	EZR RDX MSN	1.20e-04	9	237	3	GO:2000643
GeneOntologyCellularComponent	clathrin vesicle coat	SYNRG CLTCL1 SNAP91 CLTC EPN3	7.05e-05	38	240	5	GO:0030125
GeneOntologyCellularComponent	cell pole	ASTN2 EZR RDX MSN	7.10e-05	20	240	4	GO:0060187
GeneOntologyCellularComponent	sarcolemma	RYR3 CLCN1 CLTC PLCB3 DMD AKAP6 EZR CACNA1C RDX MSN	7.22e-05	190	240	10	GO:0042383
GeneOntologyCellularComponent	T-tubule	CLTC AKAP6 EZR CACNA1C RDX MSN	2.97e-04	79	240	6	GO:0030315
GeneOntologyCellularComponent	replication fork protection complex	TIPIN TIMELESS	3.91e-04	3	240	2	GO:0031298
GeneOntologyCellularComponent	clathrin coat	SYNRG CLTCL1 SNAP91 CLTC EPN3	4.54e-04	56	240	5	GO:0030118
GeneOntologyCellularComponent	uropod	SELPLG EZR MSN	4.95e-04	14	240	3	GO:0001931
GeneOntologyCellularComponent	microtubule associated complex	MAP1B KIFC1 DNAH10 DNAH7 HAUS1 DNAH17 KIF4B KIF13A	5.59e-04	161	240	8	GO:0005875
GeneOntologyCellularComponent	cell trailing edge	SELPLG EZR MSN	6.14e-04	15	240	3	GO:0031254
GeneOntologyCellularComponent	microspike	PROM2 EZR	7.76e-04	4	240	2	GO:0044393
GeneOntologyCellularComponent	cell tip	EZR RDX MSN	9.02e-04	17	240	3	GO:0051286
GeneOntologyCellularComponent	microtubule organizing center	CYLD TTBK2 FBXW8 STARD9 CCNA1 MMS19 HSF1 KIFC1 EZR VPS37A APC CCDC187 CEP63 FRY EYS TBC1D31 HAUS1 CD86 CKAP2 TSKS KIF13A PDZD2	9.56e-04	919	240	22	GO:0005815
GeneOntologyCellularComponent	vesicle coat	SYNRG CLTCL1 SNAP91 CLTC EPN3	1.04e-03	67	240	5	GO:0030120
GeneOntologyCellularComponent	clathrin coat of trans-Golgi network vesicle	SYNRG CLTCL1 CLTC	1.07e-03	18	240	3	GO:0030130
GeneOntologyCellularComponent	microtubule	CYLD MAP1B EML5 CLTC KIFC1 MID2 DNAH10 APC DNAH7 HAUS1 DNAH17 KIF4B FHDC1 CKAP2 KIF13A	1.34e-03	533	240	15	GO:0005874
Domain	SPEC	TRIO DMD AKAP6 KALRN DSP SYNE1	2.76e-06	32	238	6	SM00150
Domain	Spectrin/alpha-actinin	TRIO DMD AKAP6 KALRN DSP SYNE1	2.76e-06	32	238	6	IPR018159
Domain	-	STARD9 MCRS1 PHF12 APLF SLC4A1AP KIF13A	5.69e-06	36	238	6	2.60.200.20
Domain	FHA_dom	STARD9 MCRS1 PHF12 APLF SLC4A1AP KIF13A	5.69e-06	36	238	6	IPR000253
Domain	ERM_C_dom	EZR RDX MSN	8.10e-06	4	238	3	IPR011259
Domain	ERM	EZR RDX MSN	8.10e-06	4	238	3	PF00769
Domain	ERM	EZR RDX MSN	8.10e-06	4	238	3	IPR011174
Domain	BROMODOMAIN_2	TRIM66 KMT2A TAF1 BAZ2A BRD7 EP300	1.24e-05	41	238	6	PS50014
Domain	Bromodomain	TRIM66 KMT2A TAF1 BAZ2A BRD7 EP300	1.44e-05	42	238	6	IPR001487
Domain	-	TRIM66 KMT2A TAF1 BAZ2A BRD7 EP300	1.44e-05	42	238	6	1.20.920.10
Domain	BROMO	TRIM66 KMT2A TAF1 BAZ2A BRD7 EP300	1.44e-05	42	238	6	SM00297
Domain	Spectrin_repeat	TRIO DMD KALRN DSP SYNE1	2.98e-05	29	238	5	IPR002017
Domain	SMAD_FHA_domain	STARD9 MCRS1 PHF12 APLF SLC4A1AP KIF13A	5.01e-05	52	238	6	IPR008984
Domain	Clathrin	CLTCL1 TGFBRAP1 CLTC	6.89e-05	7	238	3	PF00637
Domain	Moesin_tail	EZR RDX MSN	6.89e-05	7	238	3	IPR008954
Domain	CHCR	CLTCL1 TGFBRAP1 CLTC	6.89e-05	7	238	3	PS50236
Domain	BROMODOMAIN_1	TRIM66 TAF1 BAZ2A BRD7 EP300	1.01e-04	37	238	5	PS00633
Domain	Clathrin_H-chain/VPS_repeat	CLTCL1 TGFBRAP1 CLTC	1.09e-04	8	238	3	IPR000547
Domain	Bromodomain	TRIM66 TAF1 BAZ2A BRD7 EP300	1.15e-04	38	238	5	PF00439
Domain	Clathrin_H-chain_propeller_rpt	CLTCL1 CLTC	1.62e-04	2	238	2	IPR022365
Domain	Cell_Morphogen_C	FRYL FRY	1.62e-04	2	238	2	IPR025481
Domain	Aquaporin_12	AQP12A AQP12B	1.62e-04	2	238	2	IPR023265
Domain	Clathrin_H-chain_propeller_N	CLTCL1 CLTC	1.62e-04	2	238	2	IPR001473
Domain	Clathrin_H-chain_link/propller	CLTCL1 CLTC	1.62e-04	2	238	2	IPR016025
Domain	Znf_piccolo	BSN PCLO	1.62e-04	2	238	2	IPR008899
Domain	Cell_morpho_N	FRYL FRY	1.62e-04	2	238	2	IPR025614
Domain	Clathrin-link	CLTCL1 CLTC	1.62e-04	2	238	2	PF09268
Domain	-	CLTCL1 CLTC	1.62e-04	2	238	2	2.130.10.110
Domain	Clathrin_heavy_chain	CLTCL1 CLTC	1.62e-04	2	238	2	IPR016341
Domain	MOR2-PAG1_mid	FRYL FRY	1.62e-04	2	238	2	IPR029473
Domain	MOR2-PAG1_mid	FRYL FRY	1.62e-04	2	238	2	PF14228
Domain	MOR2-PAG1_C	FRYL FRY	1.62e-04	2	238	2	PF14225
Domain	MOR2-PAG1_N	FRYL FRY	1.62e-04	2	238	2	PF14222
Domain	Clathrin_propel	CLTCL1 CLTC	1.62e-04	2	238	2	PF01394
Domain	zf-piccolo	BSN PCLO	1.62e-04	2	238	2	PF05715
Domain	Clathrin_H-chain_linker_core	CLTCL1 CLTC	1.62e-04	2	238	2	IPR015348
Domain	Spectrin	TRIO DMD KALRN SYNE1	1.88e-04	23	238	4	PF00435
Domain	FHA	STARD9 MCRS1 SLC4A1AP KIF13A	4.14e-04	28	238	4	SM00240
Domain	Clathrin_H-chain_linker	CLTCL1 CLTC	4.81e-04	3	238	2	IPR012331
Domain	Aquaporin_11/12	AQP12A AQP12B	4.81e-04	3	238	2	IPR016697
Domain	CLH	CLTCL1 CLTC	4.81e-04	3	238	2	SM00299
Domain	FHA_DOMAIN	MCRS1 PHF12 SLC4A1AP KIF13A	6.17e-04	31	238	4	PS50006
Domain	FHA	STARD9 MCRS1 SLC4A1AP KIF13A	6.17e-04	31	238	4	PF00498
Domain	AT_hook	KMT2A CCDC71 BAZ2A	1.01e-03	16	238	3	PF02178
Domain	ARM-type_fold	CLTCL1 RYR3 CLTC MMS19 MROH9 APC ZNFX1 APOB FRYL HUWE1 PPP2R1A EIF4G3	1.42e-03	339	238	12	IPR016024
Domain	ZF_ZZ_2	DMD NBR1 EP300	1.45e-03	18	238	3	PS50135
Domain	ZF_ZZ_1	DMD NBR1 EP300	1.45e-03	18	238	3	PS01357
Domain	ZZ	DMD NBR1 EP300	1.45e-03	18	238	3	PF00569
Domain	BPI/LBP	BPI PLTP	1.58e-03	5	238	2	IPR030675
Domain	Lipid-bd_serum_glycop_CS	BPI PLTP	1.58e-03	5	238	2	IPR017954
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	PABIR1 CYLD SYNRG HIVEP1 MAP1B TRIO EDC4 STARD9 CCSER2 KMT2A FOXO1 USP53 DSP COBLL1 RAB11FIP2 APC FRYL CBL DNAH7 AASS PLEKHA3 ANKRD17 CKAP2 EIF4G3 KIF13A SRRM2 DOP1A CRTC2	2.01e-11	861	244	28	36931259
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	BDP1 HIF1A MAP1B TRIO ERV3-1 BTBD9 SESN1 MRTFB TECPR2 ATXN2 PROM2 TGFBRAP1 ASTN2 CHD6 CAMTA1 USP53 CACNA1C VPS37A MID2 PCDHGB1 ST7 FRYL HUWE1 THAP4 INTS6 PPP2R3A TRNT1 CMIP PRKAG1 ZFHX2 ANKRD17 CKAP2 EIF4G3 NBR1 EP300 DOP1A PDZD2	2.48e-11	1489	244	37	28611215
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	CYLD ANKHD1 ASAP1 TTBK2 EML5 CLTC CCSER2 TIMELESS CAMTA1 PLXNB1 AKAP6 DMTF1 EZR SCRN3 NRDC APC APOB FRYL RHOT2 HUWE1 FAM171B AKAP12 CEP63 TRNT1 TBC1D31 HAUS1 UNC5C SAFB2 ANKRD17 CKAP2 KIF13A	3.96e-11	1084	244	31	11544199
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	KANSL1L HIVEP1 SOCS6 ANKHD1 SPATA31D4 SPATA31D3 STARD9 GLI3 BSN HSF1 KALRN SYNE1 DNAH7 AKAP12 SRRM2	1.29e-10	233	244	15	37704626
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CYLD TRIO SIRPB1 BTBD9 EDC4 SNAP91 ATXN2 CLTC BSN EZR RGPD2 KALRN SYNE1 APC RDX ZNFX1 HUWE1 AKAP12 MSN PPP2R1A FRY BRD7 DCHS1 SAFB2 ANKRD17 KIF4B CAPRIN1 XRCC6	2.59e-10	963	244	28	28671696
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MYH11 CLTCL1 MAP1B CENPC CAGE1 CREBRF RINT1 SNAP91 STARD9 CLTC KMT2A CHD6 DMD BSN ZNF541 EZR CACNA1C RGPD2 RARG PCDHGB1 DSP SYNE1 PCLO RDX APOB MSN TRNT1 TBC1D31 UNC5C SAFB2 UGGT2 EIF4G3 XRCC6 DOP1A	6.79e-10	1442	244	34	35575683
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	CENPC C9orf78 EDC4 TTBK2 RINT1 SERPINB12 TIPIN CLTC CCSER2 MCRS1 TIMELESS HSF1 KIFC1 EZR RGPD2 PCBP3 SYNE1 APC AKAP12 CEP63 EDEM3 PPP2R1A HAUS1 PRICKLE3 BRD7 WDR82 KIF4B CAPRIN1 XRCC6	3.44e-09	1155	244	29	20360068
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	PABIR1 TRIO CENPC TPRN ASAP1 RINT1 TRIM11 OCIAD1 ATXN2 CLTC DMD ADGRL2 DSP ST7 HUWE1 STAM FAM171B POSTN PPP2R1A PPP2R3A TBC1D31 HAUS1 SLC4A1AP WDR82 CKAP2 SRRM2 NBR1	7.42e-09	1049	244	27	27880917
Pubmed	A Pak1-PP2A-ERM signaling axis mediates F-actin rearrangement and degranulation in mast cells.	EZR RDX MSN PPP2R1A	1.18e-08	5	244	4	23063725
Pubmed	Sensitivity of CYP1A1 mRNA inducibility by dioxin is the same in Cyp1a2(+/+) wild-type and Cyp1a2(-/-) null mutant mice.	CYP1A2 EZR RDX MSN	1.18e-08	5	244	4	9464455
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	HIVEP1 ACADSB HORMAD1 TTBK2 MCRS1 CHD6 BSN PHF12 MUC16 ZNFX1 RHOT2 MED1 CBL DNAH7 ANKRD36B AASS ASXL3 UNC5C ANKRD17 EP300	3.15e-08	638	244	20	31182584
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	CYLD TRIO RYR3 TRIM66 NECAB1 CLTC ASTN2 MCRS1 CHD6 TAF1 SGSM3 AKAP6 EZR KALRN DSP SYNE1 APC RDX ZNFX1 HUWE1 STAM CEP63 THAP4 FRY CKAP2 EIF4G3 CAPRIN1 EP300 XRCC6	3.54e-08	1285	244	29	35914814
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ZC3H14 SYNRG MAP1B CDK12 EDC4 ANKHD1 MRTFB CLTC KMT2A TAF1 EZR DSP HUWE1 MED1 CBL PPP2R1A BAZ2A EP300	8.09e-08	549	244	18	38280479
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	KANSL1L HIVEP1 TRIO SOCS6 ASAP1 CLTC TAF1 AKAP6 EZR KALRN DSP SYNE1 RDX AKAP12 MSN LONRF3 XRCC6	1.03e-07	497	244	17	23414517
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	MAP1B CDK12 ANKHD1 RINT1 KMT2A TIMELESS PLCB3 PLXNB1 KIFC1 NRDC APC RDX ZNFX1 SACM1L MSN ANKRD17 UGGT2 DBR1 CRTC2	2.06e-07	650	244	19	38777146
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	MYH11 TRIO CLTC MMS19 DSP ZNFX1 FRYL MED1 ANKRD17 CAPRIN1 XRCC6	2.16e-07	202	244	11	33005030
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ZC3H14 HIVEP1 MAP1B CENPC CDK12 SNAP91 ATXN2 RECQL5 CLTC KMT2A TAF1 KIFC1 PCBP3 DSP CASP8 MED1 SLC4A1AP BAZ2A BRD7 SAFB2 SNRPA SRRM2 XRCC6	3.24e-07	954	244	23	36373674
Pubmed	The ezrin-like family of tyrosine kinase substrates: receptor-specific pattern of tyrosine phosphorylation and relationship to malignant transformation.	EZR RDX MSN	3.41e-07	3	244	3	8479753
Pubmed	Characterization of lens fiber cell triton insoluble fraction reveals ERM (ezrin, radixin, moesin) proteins as major cytoskeletal-associated proteins.	EZR RDX MSN	3.41e-07	3	244	3	18261459
Pubmed	Expression, localization, and binding activity of the ezrin/radixin/moesin proteins in the mouse testis.	EZR RDX MSN	3.41e-07	3	244	3	19064715
Pubmed	Differential involvement of ezrin/radixin/moesin proteins in sphingosine 1-phosphate-induced human pulmonary endothelial cell barrier enhancement.	EZR RDX MSN	3.41e-07	3	244	3	21864676
Pubmed	Differential expression of ezrin/radixin/moesin (ERM) and ERM-associated adhesion molecules in the blastocyst and uterus suggests their functions during implantation.	EZR RDX MSN	3.41e-07	3	244	3	14613898
Pubmed	Inhibition of cell adhesion by phosphorylated Ezrin/Radixin/Moesin.	EZR RDX MSN	3.41e-07	3	244	3	26555866
Pubmed	Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation.	EZR RDX MSN	3.41e-07	3	244	3	16889625
Pubmed	Effect of knockdown of ezrin, radixin, and moesin on P-glycoprotein function in HepG2 cells.	EZR RDX MSN	3.41e-07	3	244	3	21837648
Pubmed	Activation of Ras requires the ERM-dependent link of actin to the plasma membrane.	EZR RDX MSN	3.41e-07	3	244	3	22132106
Pubmed	Activation of PKC induces leukocyte adhesion by the dephosphorylation of ERM.	EZR RDX MSN	3.41e-07	3	244	3	31843195
Pubmed	Increased phosphorylation of ezrin/radixin/moesin proteins contributes to proliferation of rheumatoid fibroblast-like synoviocytes.	EZR RDX MSN	3.41e-07	3	244	3	21278069
Pubmed	ERM stable knockdown by siRNA reduced in vitro migration and invasion of human SGC-7901 cells.	EZR RDX MSN	3.41e-07	3	244	3	21352885
Pubmed	Dmoesin controls actin-based cell shape and polarity during Drosophila melanogaster oogenesis.	EZR RDX MSN	3.41e-07	3	244	3	12360288
Pubmed	Are ERM (ezrin/radixin/moesin) proteins targets for autoantibodies in demyelinating neuropathies?	EZR RDX MSN	3.41e-07	3	244	3	25286001
Pubmed	Ezrin/radixin/moesin proteins are high affinity targets for ADP-ribosylation by Pseudomonas aeruginosa ExoS.	EZR RDX MSN	3.41e-07	3	244	3	15252013
Pubmed	The amino-terminal domains of the ezrin, radixin, and moesin (ERM) proteins bind advanced glycation end products, an interaction that may play a role in the development of diabetic complications.	EZR RDX MSN	3.41e-07	3	244	3	12734202
Pubmed	Ezrin, radixin, and moesin are phosphorylated in response to 2-methoxyestradiol and modulate endothelial hyperpermeability.	EZR RDX MSN	3.41e-07	3	244	3	21659656
Pubmed	Human ezrin-moesin-radixin proteins modulate hepatitis C virus infection.	EZR RDX MSN	3.41e-07	3	244	3	23703860
Pubmed	Ezrin and moesin function together to promote T cell activation.	EZR RDX MSN	3.41e-07	3	244	3	19124745
Pubmed	Ezrin-radixin-moesin family proteins are involved in parvovirus replication and spreading.	EZR RDX MSN	3.41e-07	3	244	3	19321616
Pubmed	Deciphering brain-specific transcriptomic expression of Ezr, Rad and Msn genes in the development of Mus musculus.	EZR RDX MSN	3.41e-07	3	244	3	29906485
Pubmed	Nuclear ERM (ezrin, radixin, moesin) proteins: regulation by cell density and nuclear import.	EZR RDX MSN	3.41e-07	3	244	3	15149851
Pubmed	A gene family consisting of ezrin, radixin and moesin. Its specific localization at actin filament/plasma membrane association sites.	EZR RDX MSN	3.41e-07	3	244	3	1429901
Pubmed	ERM Proteins at the Crossroad of Leukocyte Polarization, Migration and Intercellular Adhesion.	EZR RDX MSN	3.41e-07	3	244	3	32098334
Pubmed	Ezrin, Radixin, and Moesin (ERM) proteins function as pleiotropic regulators of human immunodeficiency virus type 1 infection.	EZR RDX MSN	3.41e-07	3	244	3	18295815
Pubmed	Dynamics and function of ERM proteins during cytokinesis in human cells.	EZR RDX MSN	3.41e-07	3	244	3	28889652
Pubmed	Control of adipogenesis by ezrin, radixin and moesin-dependent biomechanics remodeling.	EZR RDX MSN	3.41e-07	3	244	3	23116763
Pubmed	Induction of ezrin-radixin-moesin molecules after cryogenic traumatic brain injury of the mouse cortex.	EZR RDX MSN	3.41e-07	3	244	3	21451358
Pubmed	Differential effects of ceramide and sphingosine 1-phosphate on ERM phosphorylation: probing sphingolipid signaling at the outer plasma membrane.	EZR RDX MSN	3.41e-07	3	244	3	20679347
Pubmed	Differential expression and distribution of ezrin, radixin and moesin in human natural killer cells.	EZR RDX MSN	3.41e-07	3	244	3	12385025
Pubmed	Osmotic cell shrinkage activates ezrin/radixin/moesin (ERM) proteins: activation mechanisms and physiological implications.	EZR RDX MSN	3.41e-07	3	244	3	17977945
Pubmed	ERM-Dependent Assembly of T Cell Receptor Signaling and Co-stimulatory Molecules on Microvilli prior to Activation.	EZR RDX MSN	3.41e-07	3	244	3	32160548
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	NOL4 HIVEP1 CENPC C9orf78 RECQL5 KMT2A TIMELESS CHD6 TAF1 KIFC1 TSHZ3 PHF12 MED1 SLC4A1AP BAZ2A BRD7 WDR82 XRCC6	3.62e-07	608	244	18	36089195
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	PABIR1 CYLD SYNRG TICAM1 EDC4 FBXW8 MRTFB OCIAD1 MCRS1 DMD FOXO1 VPS37A ZNFX1 MON1A CBL TGFB1I1 C1orf198 HAUS1 PRICKLE3 WDR82 DBR1 SNRPA GPSM1 CRTC2	3.76e-07	1038	244	24	26673895
Pubmed	A human MAP kinase interactome.	MYH11 HIVEP1 ASAP1 CLTC CHD6 TAF1 DMD USP53 DSP SYNE1 COBLL1 APC CBL MAPKAPK5 ANKRD17 EP300	4.10e-07	486	244	16	20936779
Pubmed	Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	CYLD MYH11 CDK12 TTBK2 ADGRF5 CAMTA1 FRYL SACM1L	5.59e-07	100	244	8	10048485
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	SYNRG HIVEP1 CDK12 C9orf78 CLTC KMT2A TIMELESS PLCB3 HSF1 DSP PHF12 HUWE1 MED1 SLC4A1AP PRICKLE3 BAZ2A SAFB2 ANKRD17 SRRM2 XRCC6	6.81e-07	774	244	20	15302935
Pubmed	LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells.	CLTCL1 ADGRG4 FAT1 KMT2A DSP PCLO APC HUWE1 AKAP12 PPP2R1A FRY HAUS1 PRICKLE3 ANKRD17 SRRM2 EP300 XRCC6 CRTC2	7.41e-07	639	244	18	23443559
Pubmed	Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder.	DMTF1 CACNA1C SYNE1 PCLO	7.50e-07	11	244	4	20351715
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	CYLD SYNRG TRIO ASAP1 RINT1 MRTFB OCIAD1 USP53 DSP ST7 PHF12 APC CASP8 DNAH7 PPP2R3A C1orf198 TBC1D31 DPH5 HAUS1 AASS CKAP2	7.73e-07	853	244	21	28718761
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	MYH11 CLTCL1 MAP1B TTBK2 SERPINB12 CLTC MMS19 EZR RGPD2 PCBP3 DSP RDX HUWE1 AKAP12 SACM1L MSN PPP2R1A SNRPA	8.85e-07	647	244	18	26618866
Pubmed	Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.	TRIM66 KMT2A TAF1 DNAH7 BAZ2A BRD7 EP300	1.02e-06	75	244	7	25593309
Pubmed	Human transcription factor protein interaction networks.	CYLD NOL4 HIVEP1 EDC4 ANKHD1 FAT1 ATXN2 GLI3 RECQL5 KMT2A MCRS1 CHD6 TAF1 KIFC1 TSHZ3 DNAH10 PHF12 RHOT2 MSN PPP2R1A TTC31 BRD7 ANKRD17 STK40 SRRM2 CAPRIN1 EP300 XRCC6	1.06e-06	1429	244	28	35140242
Pubmed	Functional proteomics mapping of a human signaling pathway.	HIVEP1 CDK12 TPRN MRTFB CHD6 EPN3 DMTF1 RHOT2 E4F1 HUWE1 STAM EPG5 TGFB1I1 PPP2R1A SNRPA KIF13A XRCC6	1.14e-06	591	244	17	15231748
Pubmed	Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.	TRIO SNAP91 CCSER2 DMD AKAP6 KALRN SYNE1 FRYL CEP63	1.32e-06	151	244	9	17043677
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	CYLD NOL4 TPRN SIRPB1 ANKHD1 TRIM66 FAT1 EML5 GLI3 MCRS1 MMS19 TAF1 ADGRL2 PHF12 OAS3 RHOT2 EDEM3 INTS6 BAZ2A BRD7 ANKRD17 LONRF3 SRRM2 EP300	1.34e-06	1116	244	24	31753913
Pubmed	CPI-17 drives oncogenic Ras signaling in human melanomas via Ezrin-Radixin-Moesin family proteins.	EZR RDX MSN	1.36e-06	4	244	3	27793041
Pubmed	The NHE1 Na+/H+ exchanger recruits ezrin/radixin/moesin proteins to regulate Akt-dependent cell survival.	EZR RDX MSN	1.36e-06	4	244	3	15096511
Pubmed	The ERM proteins interact with the HOPS complex to regulate the maturation of endosomes.	EZR RDX MSN	1.36e-06	4	244	3	21148287
Pubmed	Rho-ROCK-dependent ezrin-radixin-moesin phosphorylation regulates Fas-mediated apoptosis in Jurkat cells.	EZR RDX MSN	1.36e-06	4	244	3	18941185
Pubmed	Proteomic profiling in pancreatic cancer with and without lymph node metastasis.	EZR RDX MSN	1.36e-06	4	244	3	19152423
Pubmed	Normal development of mice and unimpaired cell adhesion/cell motility/actin-based cytoskeleton without compensatory up-regulation of ezrin or radixin in moesin gene knockout.	EZR RDX MSN	1.36e-06	4	244	3	9890997
Pubmed	Phosphorylated ERM is responsible for increased T cell polarization, adhesion, and migration in patients with systemic lupus erythematosus.	EZR RDX MSN	1.36e-06	4	244	3	17237445
Pubmed	Mutagenesis of the ezrin-radixin-moesin binding domain of L-selectin tail affects shedding, microvillar positioning, and leukocyte tethering.	EZR RDX MSN	1.36e-06	4	244	3	15178693
Pubmed	Cortical mechanics and meiosis II completion in mammalian oocytes are mediated by myosin-II and Ezrin-Radixin-Moesin (ERM) proteins.	EZR RDX MSN	1.36e-06	4	244	3	20660156
Pubmed	In Vitro and in Vivo Characterization of Molecular Interactions between Calmodulin, Ezrin/Radixin/Moesin, and L-selectin.	EZR RDX MSN	1.36e-06	4	244	3	19129194
Pubmed	Two Sides of the Coin: Ezrin/Radixin/Moesin and Merlin Control Membrane Structure and Contact Inhibition.	EZR RDX MSN	1.36e-06	4	244	3	31018575
Pubmed	Ezrin is a component of the HIV-1 virological presynapse and contributes to the inhibition of cell-cell fusion.	EZR RDX MSN	1.36e-06	4	244	3	24760896
Pubmed	Spatial regulation of cyclic AMP-Epac1 signaling in cell adhesion by ERM proteins.	EZR RDX MSN	1.36e-06	4	244	3	20855527
Pubmed	Functional binding interaction identified between the axonal CAM L1 and members of the ERM family.	EZR RDX MSN	1.36e-06	4	244	3	12070130
Pubmed	Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis.	EZR RDX MSN	1.36e-06	4	244	3	19890007
Pubmed	The lipid 5-phoshatase SHIP2 controls renal brush border ultrastructure and function by regulating the activation of ERM proteins.	EZR RDX MSN	1.36e-06	4	244	3	28302370
Pubmed	Anoctamin 1 (Tmem16A) Ca2+-activated chloride channel stoichiometrically interacts with an ezrin-radixin-moesin network.	EZR RDX MSN	1.36e-06	4	244	3	22685202
Pubmed	CD43 interaction with ezrin-radixin-moesin (ERM) proteins regulates T-cell trafficking and CD43 phosphorylation.	EZR RDX MSN	1.36e-06	4	244	3	21289089
Pubmed	Human immunodeficiency virus (HIV)-1 proteins and cytoskeleton: partners in viral life and host cell death.	EZR RDX MSN	1.36e-06	4	244	3	15818415
Pubmed	LOK is a major ERM kinase in resting lymphocytes and regulates cytoskeletal rearrangement through ERM phosphorylation.	EZR RDX MSN	1.36e-06	4	244	3	19255442
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	CYLD SYNRG MAP1B TRIO EDC4 ASAP1 CLTC BSN RGPD2 KALRN DSP PCLO RAB11FIP2 APC ZNFX1 HUWE1 FAM171B SACM1L MSN SFXN5 C1orf198 EIF4G3 CAPRIN1 GABBR1	1.91e-06	1139	244	24	36417873
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	ZC3H14 HIVEP1 CLTCL1 PEX12 TNFRSF10A ANKHD1 NT5C OCIAD1 PROM2 SCRN3 RHOT2 EPG5 MSN TGFB1I1 C1orf198 PRICKLE3 AASS UNC5C LONRF3 EIF4G3 KIF13A	2.76e-06	925	244	21	28986522
Pubmed	Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.	ZC3H14 MAP1B ANKHD1 EZR RGPD2 APC RDX MSN ANKRD17 XRCC6	3.22e-06	215	244	10	35973513
Pubmed	Interplay between RAGE, CD44, and focal adhesion molecules in epithelial-mesenchymal transition of alveolar epithelial cells.	EZR RDX MSN	3.38e-06	5	244	3	21278261
Pubmed	Vitronectin induces phosphorylation of ezrin/radixin/moesin actin-binding proteins through binding to its novel neuronal receptor telencephalin.	EZR RDX MSN	3.38e-06	5	244	3	23019340
Pubmed	Anchoring of protein kinase A by ERM (ezrin-radixin-moesin) proteins is required for proper netrin signaling through DCC (deleted in colorectal cancer).	EZR RDX MSN	3.38e-06	5	244	3	25575591
Pubmed	Activated ERM protein plays a critical role in drug resistance of MOLT4 cells induced by CCL25.	EZR RDX MSN	3.38e-06	5	244	3	23326330
Pubmed	Regulation of NK cell trafficking by CD81.	EZR RDX MSN	3.38e-06	5	244	3	19830727
Pubmed	Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic.	CLTCL1 SNAP91 CLTC	3.38e-06	5	244	3	10436022
Pubmed	Ezrin/radixin/moesin are required for the purinergic P2X7 receptor (P2X7R)-dependent processing of the amyloid precursor protein.	EZR RDX MSN	3.38e-06	5	244	3	22891241
Pubmed	The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho.	EZR RDX MSN	3.38e-06	5	244	3	10806479
Pubmed	ITAM-based interaction of ERM proteins with Syk mediates signaling by the leukocyte adhesion receptor PSGL-1.	SELPLG EZR MSN	3.38e-06	5	244	3	12387735
Pubmed	A novel role for BRCA1 in regulating breast cancer cell spreading and motility.	EZR RDX MSN	3.38e-06	5	244	3	21282464
Pubmed	Endofin is required for HD-PTP and ESCRT-0 interdependent endosomal sorting of ubiquitinated transmembrane cargoes.	SYNRG DTX3L CLTC VPS37A STAM CBL	4.09e-06	60	244	6	34761192
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	ZC3H14 MAP1B EDC4 ANKHD1 CLTC KMT2A DSP FRYL HUWE1 MSN PPP2R1A BAZ2A ANKRD17 EIF4G3 SRRM2 CAPRIN1 XRCC6	4.34e-06	653	244	17	22586326
Pubmed	Genetic and molecular control of folate-homocysteine metabolism in mutant mice.	GLI3 APC APOB	6.72e-06	6	244	3	12016514
Pubmed	Gene expression in temporal lobe epilepsy is consistent with increased release of glutamate by astrocytes.	EZR RDX MSN	6.72e-06	6	244	3	17515952
Interaction	YWHAG interactions	PABIR1 CYLD SYNRG HIVEP1 CDK12 SOCS6 EDC4 TNFRSF10A STARD9 CLTC CCSER2 KMT2A FOXO1 USP53 DSP COBLL1 RAB11FIP2 APC FRYL HUWE1 CBL MAPKAPK5 DNAH7 PPP2R1A PRICKLE3 AASS PLEKHA3 ANKRD17 CKAP2 EIF4G3 KIF13A SRRM2 NBR1 PRLR DOP1A CRTC2	4.90e-07	1248	236	36	int:YWHAG
Interaction	BAG2 interactions	CYLD HIF1A MAP1B EDC4 ANKHD1 TRIM66 TRIM11 MRTFB KCNH2 CLTC HSF1 FOXO1 PHF12 ZNFX1 HUWE1 STAM CBL STK40 CKAP2 EIF4G3 SRRM2 EP300 XRCC6	1.24e-06	622	236	23	int:BAG2
Interaction	YWHAH interactions	PABIR1 CYLD ZC3H14 SYNRG MYH11 HIVEP1 TRIO SOCS6 EDC4 KCNH2 STARD9 CCSER2 KMT2A FOXO1 USP53 DSP COBLL1 RAB11FIP2 APC FRYL HUWE1 MED1 CBL DNAH7 PRICKLE3 AASS PLEKHA3 ANKRD17 EIF4G3 SRRM2 DOP1A CRTC2	1.99e-06	1102	236	32	int:YWHAH
Interaction	ENO1 interactions	CYLD MYH11 CLTCL1 MAP1B C9orf78 ANKHD1 RYR3 FBP1 HSF1 ADGRL2 FOXO1 EZR RDX ZNFX1 HUWE1 CBL MSN TDRD7 C1orf198 DPH5 ASXL3 BRD7 LONRF3 XRCC6	2.76e-06	701	236	24	int:ENO1
Interaction	SFN interactions	PABIR1 CYLD SYNRG HIF1A MYH11 MAP1B EDC4 CLTC CCSER2 KMT2A FOXO1 USP53 COBLL1 APC FRYL CBL AASS ANKRD17 SNRPA KIF13A SRRM2 DOP1A	2.31e-05	692	236	22	int:SFN
Interaction	LRRC31 interactions	MYH11 TRIO CLTC MMS19 DSP ZNFX1 FRYL MED1 ANKRD17 CAPRIN1 XRCC6	3.15e-05	205	236	11	int:LRRC31
Interaction	IPO5 interactions	CYLD HIF1A C9orf78 OCIAD1 CLTC CAMTA1 HSF1 EZR RHOT2 HUWE1 CBL MSN PPP2R1A HAUS1 NBR1 EP300	3.23e-05	414	236	16	int:IPO5
Interaction	GFI1B interactions	RINT1 ATXN2 TIPIN TIMELESS TAF1 MID2 KALRN APC MON1A	3.28e-05	136	236	9	int:GFI1B
Interaction	KRT18 interactions	MAP1B CREBRF FBP1 CLTC USP53 DSP APC CASP8 HUWE1 CBL CEP63 PPP2R1A TBC1D31 HAUS1 NBR1 EP300	3.74e-05	419	236	16	int:KRT18
Interaction	BAX interactions	BDP1 C9orf78 NT5C OCIAD1 SERPINB12 TAF1 CASP8 LONRF3 XRCC6	4.60e-05	142	236	9	int:BAX
GeneFamily	Zinc fingers\|Zinc fingers PARP-type\|Poly(ADP-ribose) polymerases	BSN PCLO APLF	2.51e-04	15	153	3	26
GeneFamily	Dyneins, axonemal	DNAH10 DNAH7 DNAH17	3.70e-04	17	153	3	536
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	DMD NBR1 EP300	4.42e-04	18	153	3	91
GeneFamily	Kinesins\|Pleckstrin homology domain containing	STARD9 KIFC1 KIF4B KIF13A	6.10e-04	46	153	4	622
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	BDP1 CHD6 ZNF541 DMTF1	1.05e-03	53	153	4	532
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	AKAP6 EZR AKAP12	1.85e-03	29	153	3	396
Coexpression	LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX	BDP1 KANSL1L BTBD9 FREM1 ADGRF5 FOXO1 EZR NRDC DSP COBLL1 ABCA5	1.83e-07	152	242	11	M39239
Coexpression	MURARO_PANCREAS_BETA_CELL	MAP1B CENPC SESN1 ASAP1 CREBRF OCIAD1 SNAP91 ATXN2 KCNH2 CLTC CCSER2 ETNK1 FOXO1 TSHZ3 VPS37A NRDC DSP COBLL1 PCLO APC HUWE1 ABCA5 BRD7 EIF4G3 KIF13A GPSM1 PDZD2	2.27e-07	946	242	27	M39169
Coexpression	GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN	TGFBRAP1 CHD6 DMTF1 COBLL1 RAB11FIP2 APC E4F1 CBL SFXN5 CMIP DNAH17	2.78e-06	200	242	11	M9459
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	ZC3H14 HIF1A HIVEP1 MAP1B TRIO CENPC SOCS6 FAT1 HEG1 ATXN2 CCSER2 DMD APC CASP8 RDX FRYL STAM MED1 TDRD7 PPP2R3A TBC1D31 ANKRD17 EIF4G3	5.11e-06	856	242	23	M4500
Coexpression	GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN	APCDD1 ATXN2 PROB1 TIMELESS FOXO1 SELPLG MED1 INTS6 SRRM2 GPSM1	1.74e-05	199	242	10	M6964
Coexpression	FIRESTEIN_PROLIFERATION	CYLD TRIO ETNK1 TAF1 AKAP6 KALRN TSKS EP300 XRCC6	2.53e-05	166	242	9	M5354
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	BDP1 MAP1B MRTFB SNAP91 ADGRL2 CACNA1C KALRN SYNE1 PCLO ANKRD36B FRY ABCA5	1.23e-09	200	244	12	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	MYH11 MAP1B DMD AKAP6 USP53 CACNA1C KALRN AKAP12 POSTN FRY UNC5C	7.48e-09	187	244	11	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP1B MRTFB SNAP91 ADGRL2 CACNA1C KALRN SYNE1 PCLO ANKRD36B FRY ABCA5	1.22e-08	196	244	11	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NOL4 FREM1 RYR3 FAT1 DMD DNAH10 KALRN PCLO APOB ASXL3	7.67e-08	184	244	10	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NOL4 FREM1 RYR3 FAT1 DMD DNAH10 KALRN PCLO APOB ASXL3	7.67e-08	184	244	10	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NOL4 FREM1 RYR3 FAT1 DMD DNAH10 KALRN PCLO APOB ASXL3	7.67e-08	184	244	10	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CNNM2 MYH11 MAP1B FAT1 DMD AKAP6 CACNA1C KALRN ST7 SYNE1	8.49e-08	186	244	10	4780af76237d7af2abbe2d8d5530cdf53e3ed0b7
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	CNNM2 MYH11 RYR3 DMD AKAP6 CACNA1C KALRN COBLL1 FRY KIF13A	9.38e-08	188	244	10	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP1B MRTFB SNAP91 ADGRL2 CACNA1C KALRN SYNE1 PCLO FRY ABCA5	1.52e-07	198	244	10	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP1B MRTFB SNAP91 ADGRL2 CACNA1C KALRN SYNE1 PCLO FRY ABCA5	1.52e-07	198	244	10	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP1B MRTFB SNAP91 ADGRL2 CACNA1C KALRN SYNE1 PCLO FRY ABCA5	1.52e-07	198	244	10	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RYR3 GLI3 PLXNB1 SYNE1 APC FAM171B DNAH7 SFXN5 UNC5C GABBR1	1.67e-07	200	244	10	07d942803360e1a1e8e131d6e31c726dd0db1a0b
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_only / Treatment groups by lineage, cell group, cell type	CNNM2 MYH11 MAP1B FAT1 STARD9 TSHZ3 TGFB1I1 POSTN PRLR PDZD2	1.67e-07	200	244	10	69edc375d85689300d1dbc1217fedc40063ecdcb
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYH11 MAP1B FAT1 KCNH2 DMD AKAP6 TSHZ3 SYNE1 TGFB1I1 POSTN	1.67e-07	200	244	10	dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
ToppCell	VE-Treg-naive_CD4\|VE / Condition, Cell_class and T cell subcluster	ZXDC CENPC SIRPB1 KCNH2 STAM DNAH7 AASS GPSM1 NBR1	2.09e-07	156	244	9	6501baf73616e702946de9fb13d267e30a68888b
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell-D122\|Adult / Lineage, Cell type, age group and donor	MYH11 MAP1B RYR3 ALPK3 DMD CACNA1C KALRN AKAP12 UNC5C	2.73e-07	161	244	9	64891f6f2ee1693c8481e951b9346e2f92d602e3
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CNNM2 KL PROM2 ADGRL2 PLXNB1 EPN3 COBLL1 ANKRD36B UNC5C	6.07e-07	177	244	9	c9e8149639551a4c8daa90fcb2b895fdcff2e2ba
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	MYH11 DMD AKAP6 CACNA1C KALRN COBLL1 FRY UNC5C KIF13A	8.02e-07	183	244	9	818fd886e0188091310825f9145fa53328f2c979
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CNNM2 MYH11 MAP1B FAT1 DMD PCBP3 POSTN PRLR PDZD2	8.39e-07	184	244	9	689a8af81a79a4bb3123cfa01958c953eab5de98
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CNNM2 MYH11 FAT1 STARD9 DMD ST7 POSTN PRLR PDZD2	8.39e-07	184	244	9	327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CNNM2 MYH11 MAP1B FAT1 DMD AKAP6 CACNA1C ST7 TGFB1I1	9.18e-07	186	244	9	a95744b8649096bd7cfc3591a02841fa411085b3
ToppCell	COPD-Stromal-SMC\|Stromal / Disease state, Lineage and Cell class	MYH11 MAP1B NECAB1 ALPK3 DMD AKAP6 CACNA1C CBL FRY	1.00e-06	188	244	9	9ffef4b01d0ddd6913c9ed6be79aeaaabd5e41ed
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CNNM2 MYH11 MAP1B FAT1 DMD AKAP6 CACNA1C ST7 TGFB1I1	1.05e-06	189	244	9	975e7aa3b862a8b07c2ab8426a14f5cc54998aca
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CNNM2 MYH11 MAP1B FAT1 DMD CACNA1C SYNE1 TGFB1I1 POSTN	1.05e-06	189	244	9	7ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	CNNM2 MYH11 RYR3 DMD AKAP6 KALRN COBLL1 FRY KIF13A	1.05e-06	189	244	9	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	Control-Stromal-SMC\|Stromal / Disease state, Lineage and Cell class	MYH11 MAP1B ADGRF5 DMD AKAP6 CACNA1C KALRN TGFB1I1 FRY	1.15e-06	191	244	9	2da83c493e60ad0278848957645277d76737a188
ToppCell	droplet-Kidney-nan-18m-Epithelial-Epcam_____kidney_distal_convoluted_tubule_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNNM2 ACADSB UROC1 KL PROM2 CAMTA1 EPN3 KALRN SLITRK4	1.20e-06	192	244	9	6fb56d062c35617b18b927704bf5fba894faed81
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TRIO BTBD9 ANKHD1 ASAP1 FOXO1 CMIP ANKRD17 EIF4G3 EPB42	1.25e-06	193	244	9	779276e775cb2492e8dd36436295a536084a6415
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NOL4 MAP1B SOCS6 EML5 SNAP91 NECAB1 AKAP6 PCBP3 PCLO	1.25e-06	193	244	9	a189d46c39067b717509cd144e0225cc93d7731d
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	ASTN2 DMD ADGRL2 AKAP6 CACNA1C ST7 FRY PPP2R3A PDZD2	1.30e-06	194	244	9	c3535f7cc0076653c72db582047cff053c322397
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CNNM2 KL PROM2 HSF1 ADGRL2 PLXNB1 COBLL1 SFXN5 ABCA5	1.42e-06	196	244	9	f40d10ea7714067585493fdc89744714aa427de8
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYH11 MAP1B DMD AKAP6 CACNA1C KALRN AKAP12 FRY UNC5C	1.48e-06	197	244	9	bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYH11 MAP1B NECAB1 STARD9 ALPK3 AKAP6 CACNA1C KALRN SYNE1	1.54e-06	198	244	9	c12e7511628db819a52959bb68580e27c00c2e41
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP1B SNAP91 ADGRL2 CACNA1C KALRN PCLO ANKRD36B FRY ABCA5	1.54e-06	198	244	9	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYH11 MAP1B DMD AKAP6 CACNA1C KALRN AKAP12 TGFB1I1 UNC5C	1.61e-06	199	244	9	b1753474152b82a0b811b9878c890a359e14919a
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CNNM2 MYH11 MAP1B FAT1 DMD AKAP6 SYNE1 TGFB1I1 POSTN	1.68e-06	200	244	9	f599e4b051ac3dad11ad437e98dc8ea6754cca53
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RYR3 GLI3 PLXNB1 SYNE1 APC FAM171B DNAH7 SFXN5 GABBR1	1.68e-06	200	244	9	d0812817ef99608994193787a62d39adeb2070ca
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BDP1 CENPC DTX3L KMT2A CASP8 OAS3 FRYL BRD7 SRRM2	1.68e-06	200	244	9	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte\|LPS_only / Treatment groups by lineage, cell group, cell type	CNNM2 MYH11 MAP1B FAT1 DMD AKAP6 SYNE1 TGFB1I1 POSTN	1.68e-06	200	244	9	8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CNNM2 MYH11 MAP1B FAT1 DMD AKAP6 SYNE1 TGFB1I1 POSTN	1.68e-06	200	244	9	b22cae282591d8dead9869c2adbb9632615f50f7
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RYR3 GLI3 PLXNB1 SYNE1 APC FAM171B DNAH7 SFXN5 GABBR1	1.68e-06	200	244	9	cd54ddf1919c98e84b7e4aba85b374fc8b407206
ToppCell	LPS_only-Mesenchymal_myocytic\|LPS_only / Treatment groups by lineage, cell group, cell type	CNNM2 MYH11 MAP1B FAT1 DMD AKAP6 SYNE1 TGFB1I1 POSTN	1.68e-06	200	244	9	8bc9923f82bfb836e2f524204c92050edeae8ca5
ToppCell	LPS_IL1RA-Mesenchymal_myocytic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CNNM2 MYH11 MAP1B FAT1 DMD AKAP6 SYNE1 TGFB1I1 POSTN	1.68e-06	200	244	9	77631c471cc5d453a749784f838cfa6408caf09b
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell\|Adult / Lineage, Cell type, age group and donor	MYH11 MAP1B KCNH2 DMD AKAP6 CACNA1C KALRN UNC5C	5.00e-06	172	244	8	c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell\|Adult / Lineage, Cell type, age group and donor	MYH11 MAP1B RYR3 DMD AKAP6 CACNA1C KALRN UNC5C	5.22e-06	173	244	8	a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NECAB1 BSN CACNA1C PCLO FRYL ZFHX2 PRLR DOP1A	5.45e-06	174	244	8	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	COVID-19-Heart-VSMC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYH11 MAP1B DMD AKAP6 CACNA1C KALRN FRY UNC5C	5.68e-06	175	244	8	1125f0d3a5b2388fa77a820dea0288e824d84a82
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma\|TCGA-Brain / Sample_Type by Project: Shred V9	ACADSB CCSER2 KMT2A AKAP6 SYNE1 KIF13A NBR1 GABBR1	6.18e-06	177	244	8	e8ab340b20cd41554c3841fe980e078e878af35f
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B TPRN TTBK2 RINT1 ADGRF5 MMS19 MID2 AKAP12	6.71e-06	179	244	8	025d414ec88d5680d99c8173e70ee3bb0b694f74
ToppCell	Control-Fibroblasts-Airway_smooth_muscle\|Control / group, cell type (main and fine annotations)	MYH11 MAP1B DMD AKAP6 CACNA1C KALRN AKAP12 UNC5C	6.99e-06	180	244	8	d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYH11 MAP1B APCDD1 KCNH2 DMD TGFB1I1 POSTN CMIP	7.88e-06	183	244	8	af8d86f15a549064530d94bd47081daf59d58ecd
ToppCell	RA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	MYH11 DMD AKAP6 CACNA1C KALRN COBLL1 FRY UNC5C	7.88e-06	183	244	8	cae2ee08f985a6f005b4b8e959e465350315156a
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CNNM2 MYH11 FAT1 DMD CACNA1C ST7 TGFB1I1 POSTN	8.20e-06	184	244	8	102b6f621a5b551e622f97b12d787c080b052a72
ToppCell	3'-Child09-12-SmallIntestine-Mesenchymal-myocytic\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYH11 MAP1B APCDD1 KCNH2 DMD AKAP12 TGFB1I1 POSTN	8.20e-06	184	244	8	5cfc19ffb9f074bdf0d81c86e212a708ec141631
ToppCell	3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CREBRF HEG1 MRTFB ALPK3 TSHZ3 SYNE1 RDX PDZD2	8.54e-06	185	244	8	fa94c4a1660967f211ba095606cd0aa37d38e17a
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYH11 MAP1B FAT1 STARD9 DMD PCDHA5 UNC5C PDZD2	8.88e-06	186	244	8	888e85a025bd982d36c910db0f5a3385b1ca3b28
ToppCell	3'-Adult-Appendix-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CREBRF HEG1 MRTFB ALPK3 TSHZ3 SYNE1 RDX PDZD2	9.23e-06	187	244	8	37d8ee5c8bd6324749e5a2adef1d0482c75da80c
ToppCell	3'-Adult-Appendix-Endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CREBRF HEG1 MRTFB ALPK3 TSHZ3 SYNE1 RDX PDZD2	9.23e-06	187	244	8	ec98d5e480b08854dfd0ba6b1dc6610455f90640
ToppCell	343B-Lymphocytic-ILC-ILC-1\|343B / Donor, Lineage, Cell class and subclass (all cells)	PABIR1 ACADSB SOCS6 SCRN3 TRNT1 TBC1D31 WDR82 EPB42	9.60e-06	188	244	8	8f6b45ad82bde65e044d17f0edbc3db90d457915
ToppCell	COVID-19_Convalescent-Classical_Monocyte-cMono_3\|Classical_Monocyte / Disease condition and Cell class	ACADSB ANKHD1 KMT2A MMS19 PLCB3 MON1A SLC26A6 DOP1A	9.98e-06	189	244	8	8b6f92ccfffc743c07201bc971b3dc1a6fa14ccc
ToppCell	COVID-19_Convalescent-Classical_Monocyte-cMono_3\|COVID-19_Convalescent / Disease condition and Cell class	ACADSB ANKHD1 KMT2A MMS19 PLCB3 MON1A SLC26A6 DOP1A	9.98e-06	189	244	8	732e8dcffcb634ca2968f9170c9c4b31dd5d4206
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CNNM2 MYH11 MAP1B FAT1 DMD SYNE1 TGFB1I1 POSTN	1.08e-05	191	244	8	08042952431ca1a6fd7dfc13f36eb28643979598
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CNNM2 MYH11 FAT1 DMD CACNA1C SYNE1 TGFB1I1 POSTN	1.08e-05	191	244	8	7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4
ToppCell	Mesenchymal-vascular_smooth_muscle_cell\|World / Lineage, Cell type, age group and donor	CNNM2 MYH11 MAP1B FAT1 DMD CACNA1C KALRN FRY	1.08e-05	191	244	8	fd89fbc62aa1c73e0f659991e3bd726a0c97bd68
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 MAP1B ASAP1 GLI3 ADGRF5 DMD KALRN FRY	1.08e-05	191	244	8	7b0d42a877540dbb346a76a62403e0d5d3e07fa6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 MAP1B ASAP1 GLI3 ADGRF5 DMD KALRN FRY	1.08e-05	191	244	8	cd854b9c426924fdc84bf7f411f6dea447143e79
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-myocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYH11 MAP1B APCDD1 KCNH2 DMD TGFB1I1 POSTN CMIP	1.16e-05	193	244	8	146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	SYNRG TGFBRAP1 CLTC FRYL HUWE1 MED1 BAZ2A CAPRIN1	1.16e-05	193	244	8	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KANSL1L FAT1 ASTN2 COBLL1 PCLO DNAH7 PPP2R3A PRLR	1.16e-05	193	244	8	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYH11 MAP1B FAT1 GLI3 CACNA1C TGFB1I1 POSTN UNC5C	1.16e-05	193	244	8	5de87fc94a6e58899ef4124cf4887ed3ff96163a
ToppCell	droplet-Kidney-nan-18m-Epithelial-kidney_distal_convoluted_tubule_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNNM2 ACADSB UROC1 KL PROM2 CAMTA1 EPN3 KALRN	1.16e-05	193	244	8	fa8bcf2a5ab7b08fae98a1466a936995142b4309
ToppCell	nucseq-Mesenchymal-Myocytic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYH11 MAP1B FAT1 GLI3 CACNA1C TGFB1I1 POSTN UNC5C	1.21e-05	194	244	8	2d66091097e106c7bee22e5281f50724700bdf8d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KANSL1L FAT1 ASTN2 PLXNB1 COBLL1 PCLO DNAH7 PPP2R3A	1.21e-05	194	244	8	5eaaa81f4b2535f983c424aaef00077089526a5c
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NECAB1 ADGRF5 EZR ST7 SYNE1 COBLL1 FHDC1 PDZD2	1.21e-05	194	244	8	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	COVID-19-lung-Pericytes/_Smooth_Muscle\|lung / Disease (COVID-19 only), tissue and cell type	CNNM2 MYH11 MAP1B DMD AKAP6 CACNA1C FRY UNC5C	1.21e-05	194	244	8	5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CNNM2 FREM1 KL ADGRL2 COBLL1 SFXN5 ABCA5	1.23e-05	140	244	7	5e81fa3a19d23f0e9cae3878431ca1f78dff7238
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B CLTC KMT2A PCLO FRYL HUWE1 ABCA5 SRRM2	1.25e-05	195	244	8	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRIO CLTC PCLO CMIP ZFHX2 FHDC1 GPSM1 PRLR	1.25e-05	195	244	8	bd8e24dd598990204998d1dd853ba7a53dc0107e
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CNNM2 KL PROM2 HSF1 ADGRL2 PLXNB1 COBLL1 ABCA5	1.30e-05	196	244	8	b8350340d86e4524e9616a427e7f2e116a6fb3be
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KANSL1L FAT1 ASTN2 EZR COBLL1 PCLO DNAH7 PPP2R3A	1.30e-05	196	244	8	6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0
ToppCell	tumor_Lung-Endothelial_cells-Tip-like_ECs\|tumor_Lung / Location, Cell class and cell subclass	APCDD1 KL ADGRF5 ADGRL2 RDX POSTN FRY DCHS1	1.35e-05	197	244	8	353b76ca3e2aa4b8f51396e7121c4baa114083a0
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYH11 MAP1B STARD9 ALPK3 AKAP6 CACNA1C SYNE1 AKAP12	1.35e-05	197	244	8	ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYH11 MAP1B DMD AKAP6 CACNA1C KALRN AKAP12 UNC5C	1.40e-05	198	244	8	bd42c03e384e64f61b02618cf1a5440033bb04b2
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP1B MRTFB SNAP91 CACNA1C KALRN SYNE1 PCLO FRY	1.40e-05	198	244	8	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYH11 MAP1B FAT1 KCNH2 DMD SYNE1 TGFB1I1 POSTN	1.45e-05	199	244	8	e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b
ToppCell	Striatum-Neuronal\|Striatum / BrainAtlas - Mouse McCarroll V32	MAP1B ETNK1 CAMTA1 BSN PCLO RAB11FIP2 SLITRK4 GABBR1	1.50e-05	200	244	8	c888fd487990cad482a4ca47601cdebc0ca3f3ce
ToppCell	Hematolymphoid-Endothelial-NOSTRIN\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	HEG1 ADGRF5 ADGRL2 CACNA1C SYNE1 COBLL1 FRY PDZD2	1.50e-05	200	244	8	032df80aa5c40991e1c1e80f9d8da106e6aeaee2
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	MYH11 MAP1B FAT1 KCNH2 DMD TSHZ3 SYNE1 TGFB1I1	1.50e-05	200	244	8	c5e051f1aac8dda376c342a9932785a23450e073
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CNNM2 MYH11 MAP1B FAT1 DMD AKAP6 SYNE1 TGFB1I1	1.50e-05	200	244	8	9169a9ec8e9ab95d90a64c5a19ac666a5cf82313
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	MYH11 FAT1 KCNH2 DMD TSHZ3 SYNE1 TGFB1I1 POSTN	1.50e-05	200	244	8	9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1
ToppCell	Hematolymphoid-Endothelial-NOSTRIN---\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	HEG1 ADGRF5 ADGRL2 CACNA1C SYNE1 COBLL1 FRY PDZD2	1.50e-05	200	244	8	68fce28690246895fd33354b30960ebcc31aa4cc
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CNNM2 MYH11 MAP1B FAT1 DMD AKAP6 SYNE1 TGFB1I1	1.50e-05	200	244	8	c06426f877919bdd267ea2fd7e7973c6619832ae
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	MYH11 MAP1B FAT1 KCNH2 DMD SYNE1 TGFB1I1 POSTN	1.50e-05	200	244	8	593bf6a7c557437db9a9249a5058a46014179ef6
ToppCell	Hematolymphoid-Endothelial-NOSTRIN----L2-6\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	HEG1 ADGRF5 ADGRL2 CACNA1C SYNE1 COBLL1 FRY PDZD2	1.50e-05	200	244	8	878bbbe32e3602723aa14ef32877ab2453b8c6e5
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_only / Treatment groups by lineage, cell group, cell type	CNNM2 MYH11 MAP1B FAT1 DMD AKAP6 SYNE1 TGFB1I1	1.50e-05	200	244	8	7c62678cf408aaaf98d6df0fb27814d2007c4521
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CNNM2 MYH11 MAP1B FAT1 DMD AKAP6 SYNE1 TGFB1I1	1.50e-05	200	244	8	a3a1e35934d676c39f917652e50c502cb2f613c1
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	MAP1B NECAB1 CACNA1C KALRN PCLO SLITRK4 CMIP ASXL3	1.50e-05	200	244	8	bad32a95b759fad509401b07bc96a56687c2a592
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYH11 MAP1B DMD AKAP6 CACNA1C KALRN AKAP12 FRY	1.50e-05	200	244	8	a66449b22b39dd6987fc2c3ed160d24564234ced
ToppCell	Hematolymphoid-Endothelial-NOSTRIN-\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	HEG1 ADGRF5 ADGRL2 CACNA1C SYNE1 COBLL1 FRY PDZD2	1.50e-05	200	244	8	376b19ab5a7cd2c85f726d8ba41337d4525863e5
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYH11 MAP1B FAT1 KCNH2 DMD SYNE1 TGFB1I1 POSTN	1.50e-05	200	244	8	8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e
Drug	Dipivefrin hydrochloride [64019-93-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A	CYP1A2 TICAM1 TRIM66 KCNH2 RECQL5 KMT2A PLCB3 SGSM3 APC PPP2R3A BAZ2A SAFB2	1.45e-06	199	240	12	2744_DN
Drug	Nafronyl oxalate [3200-06-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A	CYP1A2 TRIO TICAM1 TGFBRAP1 ASTN2 SGSM3 GOSR2 EDEM3 DPH5 EIF4G3 SLC26A6	7.55e-06	195	240	11	2622_DN
Drug	Tamoxifen citrate [54965-24-1]; Down 200; 7uM; PC3; HT_HG-U133A	ZXDC HEG1 CCNA1 PLCB3 SGSM3 SCRN3 GOSR2 SLC4A1AP SAFB2 LONRF3 CAPRIN1	7.55e-06	195	240	11	2050_DN
Drug	Dobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	TRIO SOCS6 KCNH2 GLI3 RECQL5 SGSM3 PLTP CASP8 GOSR2 BAZ2A CAPRIN1	7.92e-06	196	240	11	3206_DN
Drug	Ergocryptine-alpha [511-09-1]; Down 200; 7uM; MCF7; HT_HG-U133A	KANSL1L SYNRG ACADSB SOCS6 KCNH2 RECQL5 TIMELESS CASP8 CBL BAZ2A WDR82	7.92e-06	196	240	11	4374_DN
Drug	aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A	CYLD TICAM1 EDC4 MCRS1 PLCB3 TAF1 SGSM3 COBLL1 GOSR2 PPP2R3A SLC4A1AP	8.31e-06	197	240	11	5564_DN
Drug	Coralyne chloride hydrate [38989-38-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A	KANSL1L ACADSB AVPR1B CCR4 PLTP SYNE1 COBLL1 OAS3 HUWE1 FRY BAZ2A	9.15e-06	199	240	11	2652_UP
Drug	o-nitrophenyl beta-D-fucopyranoside	SYNRG CLTCL1 SNAP91 CLTC EPN3 SYNE1 RAB11FIP2	1.31e-05	74	240	7	CID000004597
Drug	3,4-DNT	CYP1A2 NT5C RDX	2.26e-05	6	240	3	CID000011883
Drug	Disopyramide [3737-09-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A	SYNRG SOCS6 NT5C CCSER2 PLXNB1 RARG COBLL1 UGGT2 CAPRIN1 PRLR	3.56e-05	190	240	10	7439_DN
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A	MAP1B TRIO TGFBRAP1 ASTN2 TAF1 FOXO1 MED1 CBL PPP2R3A BAZ2A	3.72e-05	191	240	10	4279_DN
Drug	Pargyline hydrochloride [306-07-0]; Down 200; 20.4uM; HL60; HG-U133A	CYP1A2 CNNM2 HIVEP1 DMTF1 ST7 MED1 EDEM3 TBC1D31 DPH5 MTF1	3.72e-05	191	240	10	1418_DN
Drug	dec-5-ene	ACADSB FBP1 SYNE1	3.92e-05	7	240	3	CID000023916
Drug	Bisacodyl [603-50-9]; Down 200; 11uM; PC3; HT_HG-U133A	CYLD ZXDC ACADSB RINT1 RECQL5 CCSER2 CCNA1 FOXO1 DPH5 SRRM2	4.07e-05	193	240	10	4616_DN
Drug	Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; HL60; HG-U133A	CNNM2 HIVEP1 CLTCL1 SESN1 ATXN2 KMT2A TAF1 EDEM3 MTF1 CAPRIN1	4.07e-05	193	240	10	1412_DN
Drug	Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A	KANSL1L SOCS6 SGSM3 EZR RARG COBLL1 APC EDEM3 SAFB2 PRLR	4.07e-05	193	240	10	3841_DN
Drug	Roxarsone [121-19-7]; Down 200; 15.2uM; PC3; HT_HG-U133A	CYLD CNNM2 TRIO SOCS6 TECPR2 RARG APC CEP63 UGGT2 EIF4G3	4.25e-05	194	240	10	5051_DN
Drug	Roxithromycin [80214-83-1]; Down 200; 4.8uM; PC3; HT_HG-U133A	KANSL1L CYP1A2 CLTCL1 HEG1 SGSM3 RARG CASP8 DNAH7 CEP63 BAZ2A	4.25e-05	194	240	10	4192_DN
Drug	Sulfathiazole [72-14-0]; Up 200; 15.6uM; PC3; HG-U133A	CLTCL1 SOCS6 EDC4 BNC1 RECQL5 ETNK1 PPP2R3A MTF1 WDR82 EIF4G3	4.44e-05	195	240	10	1883_UP
Drug	Testosterone propionate [57-85-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A	KCNH2 GLI3 ASTN2 PLCB3 RARG RAB11FIP2 PRICKLE3 SAFB2 SRRM2 SLC26A6	4.44e-05	195	240	10	2649_DN
Drug	Fluvastatin sodium salt [93957-55-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A	CYP1A2 ACADSB NT5C ATXN2 GLI3 RECQL5 CCSER2 ASTN2 COBLL1 MED1	4.64e-05	196	240	10	5290_DN
Drug	Pivmecillinam hydrochloride [32887-03-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A	KANSL1L ACADSB RECQL5 ASTN2 PLCB3 TAF1 RARG COBLL1 SAFB2 TSKS	4.64e-05	196	240	10	6014_DN
Drug	Thiamphenicol [15318-45-3]; Up 200; 11.2uM; PC3; HT_HG-U133A	SOCS6 TECPR2 CCNA1 SGSM3 FOXO1 PDSS2 SCRN3 COBLL1 APC EP300	4.84e-05	197	240	10	1826_UP
Drug	Morantel tartrate [26155-31-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A	KANSL1L TICAM1 RECQL5 APC MED1 GOSR2 PPP2R3A SAFB2 KIF13A SRRM2	4.84e-05	197	240	10	1676_UP
Drug	Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; HL60; HG-U133A	PEX12 RINT1 ATXN2 TGFBRAP1 DMTF1 EZR RAB11FIP2 FRYL EDEM3 DOP1A	4.84e-05	197	240	10	1386_DN
Drug	Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A	CNNM2 TRIO TICAM1 SOCS6 TECPR2 ADGRF5 TIMELESS APC RHOT2 PRICKLE3	4.84e-05	197	240	10	3708_DN
Drug	Megestrol acetate [595-33-5]; Down 200; 10.4uM; MCF7; HT_HG-U133A	TRIM66 GLI3 RECQL5 TIMELESS PLCB3 SGSM3 FOXO1 PCLO PRICKLE3 SLC26A6	5.05e-05	198	240	10	5013_DN
Drug	Triamcinolone [124-94-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A	ZXDC HIVEP1 SOCS6 GLI3 KMT2A PLXNB1 RARG COBLL1 RHOT2 SLC26A6	5.27e-05	199	240	10	7192_DN
Drug	Gly-His-Lys acetate salt; Up 200; 1uM; MCF7; HT_HG-U133A	SYNRG SOCS6 ASAP1 TRIM66 HEG1 COBLL1 EDEM3 TBC1D31 SLC4A1AP UGGT2	5.27e-05	199	240	10	6575_UP
Drug	Mebhydroline 1,5-naphtalenedisulfonate [6153-33-9]; Down 200; 4.8uM; PC3; HT_HG-U133A	KANSL1L CLTCL1 HEG1 ASTN2 PLXNB1 RARG KALRN RHOT2 HUWE1 TSKS	5.27e-05	199	240	10	4211_DN
Drug	salicylaldehyde isonicotinoyl hydrazone	CYP1A2 HIF1A CASP8	6.23e-05	8	240	3	ctd:C413684
Disease	Colorectal Carcinoma	CYP1A2 MAP1B NT5C GGH FAT1 KL GLI3 MCRS1 DMD AKAP6 KALRN SYNE1 APC CASP8 APOB STAM AKAP12 POSTN ABCA5 DCHS1 TSKS EP300	6.10e-08	702	236	22	C0009402
Disease	unipolar depression, bipolar disorder	NOL4 CNNM2 STARD9 ASTN2 DMTF1 CACNA1C SYNE1 PCLO ASXL3	4.95e-06	156	236	9	EFO_0003761, MONDO_0004985
Disease	triglycerides to phosphoglycerides ratio	PLCB3 PLTP DNAH10 COBLL1 APOB CMIP	1.78e-05	68	236	6	EFO_0022327
Disease	Colorectal Neoplasms	CYP1A2 NT5C GGH FAT1 SYNE1 APC CASP8 POSTN ABCA5 EP300	8.58e-05	277	236	10	C0009404
Disease	triglycerides in large VLDL measurement	PLTP DNAH10 COBLL1 APOB CMIP	8.59e-05	56	236	5	EFO_0022178
Disease	total cholesterol measurement, very low density lipoprotein cholesterol measurement	PELI3 ATXN2 PLCB3 PLTP DNAH10 COBLL1 APOB PPP2R3A CMIP	8.64e-05	224	236	9	EFO_0004574, EFO_0008317
Disease	triglycerides in small VLDL measurement	PLTP DNAH10 COBLL1 APOB CMIP	1.30e-04	61	236	5	EFO_0022145
Disease	phospholipids in large VLDL measurement	PLTP DNAH10 COBLL1 APOB CMIP	1.40e-04	62	236	5	EFO_0022169
Disease	total lipids in very large VLDL measurement	PLTP DNAH10 COBLL1 APOB CMIP	1.40e-04	62	236	5	EFO_0022313
Disease	phospholipids in very large VLDL measurement	PLTP DNAH10 COBLL1 APOB CMIP	1.40e-04	62	236	5	EFO_0022299
Disease	Malignant neoplasm of breast	HIF1A TICAM1 DTX3L CLCN1 ASTN2 TIMELESS DMD PLXNB1 ZNF541 AKAP6 RARG PNLIPRP1 KALRN SYNE1 CASP8 AKAP12 EPG5 PRICKLE3 LONRF3 EP300 DOP1A	1.61e-04	1074	236	21	C0006142
Disease	Human papilloma virus infection	CCNA1 CASP8	1.90e-04	3	236	2	C0343641
Disease	Hypopigmentation disorder	GLI3 EPG5	1.90e-04	3	236	2	C0162835
Disease	total lipids in large VLDL	PLTP DNAH10 COBLL1 APOB CMIP	2.02e-04	67	236	5	EFO_0022175
Disease	free cholesterol in large VLDL measurement	PLTP DNAH10 COBLL1 APOB CMIP	2.17e-04	68	236	5	EFO_0022265
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement	PLCB3 PLTP COBLL1 APOB CMIP WDR82	2.50e-04	109	236	6	EFO_0004639, EFO_0008317, EFO_0008596
Disease	cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	PLCB3 PLTP DNAH10 COBLL1 APOB CMIP	2.63e-04	110	236	6	EFO_0008317, EFO_0008596, EFO_0010351
Disease	chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement	PLCB3 PLTP DNAH10 COBLL1 APOB CMIP	2.63e-04	110	236	6	EFO_0004574, EFO_0008317, EFO_0008596
Disease	Intellectual Disability	ZC3H14 MAP1B TRIO UROC1 TAF1 AKAP6 SYNE1 APC PPP2R1A FRY MTF1 AASS	2.81e-04	447	236	12	C3714756
Disease	triglycerides to total lipids in small HDL percentage	PLCB3 PLTP COBLL1 APOB CMIP	2.84e-04	72	236	5	EFO_0022336
Disease	Carcinoma, Transitional Cell	GGH KMT2A CHD6 EP300	3.20e-04	41	236	4	C0007138
Disease	epilepsy (implicated_via_orthology)	TRIO KCNH2 ETNK1 BSN KALRN PRICKLE3 KIF4B	3.55e-04	163	236	7	DOID:1826 (implicated_via_orthology)
Disease	body mass index, high density lipoprotein cholesterol measurement	ATXN2 DNAH10 COBLL1	4.45e-04	19	236	3	EFO_0004340, EFO_0004612
Disease	cholesteryl ester measurement, very low density lipoprotein cholesterol measurement	PELI3 ATXN2 PLTP DNAH10 COBLL1 APOB PPP2R3A CMIP	4.83e-04	225	236	8	EFO_0008317, EFO_0010351
Disease	left atrial function	FBP1 DSP PLEKHA3	6.04e-04	21	236	3	EFO_0004294
Disease	Duchenne and Becker Muscular Dystrophy	DMD POSTN	6.27e-04	5	236	2	C3542021
Disease	Becker Muscular Dystrophy	DMD POSTN	6.27e-04	5	236	2	C0917713
Disease	Acute myelomonocytic leukemia	MYH11 KMT2A	6.27e-04	5	236	2	C0023479
Disease	coronary artery disease	CYP1A2 CNNM2 MYH11 CLTCL1 MAP1B CDK12 ATXN2 ASTN2 BSN ADGRL2 DNAH10 APOB GOSR2 AKAP12 EPG5 PPP2R3A CMIP UNC5C KIF4B GPSM1 GABBR1	6.52e-04	1194	236	21	EFO_0001645
Disease	skin aging measurement	MYH11 MROH9 RAB11FIP2 CASP8 FRYL AKAP12 PRLR	6.63e-04	181	236	7	EFO_0008006
Disease	congenital diaphragmatic hernia (biomarker_via_orthology)	FREM1 CBL EP300	9.03e-04	24	236	3	DOID:3827 (biomarker_via_orthology)
Disease	quality of life during menstruation measurement, breast pressure measurement	MAP1B ANKRD17	9.35e-04	6	236	2	EFO_0009366, EFO_0009393
Disease	Muscular Dystrophy, Duchenne	DMD POSTN	9.35e-04	6	236	2	C0013264
Disease	Bladder Neoplasm	ASAP1 GGH FBXW8 KMT2A CHD6 EP300	9.45e-04	140	236	6	C0005695
Disease	bipolar I disorder	ANKHD1 TTBK2 STARD9 ASTN2 CACNA1C SYNE1	9.81e-04	141	236	6	EFO_0009963
Disease	Malignant neoplasm of urinary bladder	ASAP1 GGH FBXW8 KMT2A CHD6 EP300	9.81e-04	141	236	6	C0005684
Disease	triglycerides in medium VLDL measurement	PLTP DNAH10 COBLL1 APOB	9.88e-04	55	236	4	EFO_0022155
Disease	cholesterol to total lipids in large HDL percentage	PLTP COBLL1 APOB CMIP	9.88e-04	55	236	4	EFO_0022234
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement	PLCB3 DNAH10 COBLL1 APOB CMIP	1.01e-03	95	236	5	EFO_0004529, EFO_0008317, EFO_0008596
Disease	Cardiac Arrhythmia	CNNM2 KCNH2 CACNA1C	1.02e-03	25	236	3	C0003811
Disease	triglycerides in very large VLDL measurement	PLTP COBLL1 APOB CMIP	1.06e-03	56	236	4	EFO_0022325
Disease	triglycerides to total lipids in medium HDL percentage	PLTP COBLL1 APOB CMIP	1.06e-03	56	236	4	EFO_0022333
Disease	Adenocarcinoma of large intestine	CDK12 TAF1 APC STK40 EP300	1.06e-03	96	236	5	C1319315
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	ATXN2 PLCB3 PLTP COBLL1 APOB CMIP	1.09e-03	144	236	6	EFO_0004611, EFO_0020943
Disease	free cholesterol to total lipids in medium VLDL percentage	ATXN2 PLTP COBLL1 CMIP	1.13e-03	57	236	4	EFO_0022284
Disease	psychosis predisposition measurement	CCR4 VWA5B1 CACNA1C	1.15e-03	26	236	3	EFO_0008337
Disease	triglyceride measurement, phospholipid measurement	PLCB3 PLTP DNAH10 COBLL1 APOB CMIP	1.17e-03	146	236	6	EFO_0004530, EFO_0004639
Disease	metabolic syndrome	EDC4 KCNH2 KMT2A COBLL1 APOB PPP2R3A CMIP	1.19e-03	200	236	7	EFO_0000195
Disease	triglycerides in VLDL measurement	PLTP COBLL1 APOB CMIP	1.29e-03	59	236	4	EFO_0022326
Disease	triglycerides to total lipids in small LDL percentage	PLCB3 COBLL1 APOB CMIP	1.29e-03	59	236	4	EFO_0022337
Disease	cholesteryl esters to total lipids in large HDL percentage	PLCB3 PLTP COBLL1 CMIP	1.29e-03	59	236	4	EFO_0022248
Disease	grapefruit juice consumption measurement	CACNA1C PCLO	1.30e-03	7	236	2	EFO_0010094
Disease	X-23641 measurement	KANSL1L ACADSB	1.30e-03	7	236	2	EFO_0800854
Disease	juvenile myelomonocytic leukemia (is_implicated_in)	CBL AKAP12	1.30e-03	7	236	2	DOID:0050458 (is_implicated_in)
Disease	triglycerides to total lipids in large HDL percentage	PLTP COBLL1 APOB CMIP	1.37e-03	60	236	4	EFO_0022330
Disease	cholesterol to total lipids in medium HDL percentage	PLTP COBLL1 APOB CMIP	1.37e-03	60	236	4	EFO_0022237
Disease	free cholesterol to total lipids in medium HDL percentage	PLTP COBLL1 APOB CMIP	1.37e-03	60	236	4	EFO_0022282
Disease	stimulant use measurement	HIVEP1 ASAP1 EYS	1.43e-03	28	236	3	EFO_0600076
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	ATXN2 PLCB3 COBLL1 APOB CMIP	1.45e-03	103	236	5	EFO_0008595, EFO_0020944
Disease	Precursor Cell Lymphoblastic Leukemia Lymphoma	CYP1A2 KMT2A CASP8 EP300	1.46e-03	61	236	4	C1961102
Disease	free cholesterol in HDL measurement	PLTP COBLL1 APOB CMIP	1.46e-03	61	236	4	EFO_0022264
Disease	HDL cholesterol change measurement, physical activity	EDC4 PLTP COBLL1 CMIP	1.55e-03	62	236	4	EFO_0003940, EFO_0007805
Disease	triglycerides to total lipids in very large HDL percentage	PLTP COBLL1 APOB CMIP	1.55e-03	62	236	4	EFO_0022339
Disease	BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment	DNAH10 ST7 COBLL1 CMIP WDR82	1.58e-03	105	236	5	EFO_0007788, EFO_0008007, EFO_0008343
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement	PLCB3 DNAH10 COBLL1 APOB CMIP	1.65e-03	106	236	5	EFO_0008317, EFO_0008596
Disease	Sudden Cardiac Death	CACNA1C DSP	1.73e-03	8	236	2	C0085298
Disease	free cholesterol measurement, very low density lipoprotein cholesterol measurement	PLCB3 PLTP DNAH10 COBLL1 APOB PPP2R3A CMIP	1.79e-03	215	236	7	EFO_0008317, EFO_0008591
Disease	cholesterol in large VLDL measurement	PLTP DNAH10 COBLL1 APOB	1.84e-03	65	236	4	EFO_0021902
Disease	cholesterol in very large VLDL measurement	PLTP DNAH10 COBLL1 APOB	1.84e-03	65	236	4	EFO_0022230
Disease	free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	PLCB3 DNAH10 COBLL1 APOB CMIP	1.94e-03	110	236	5	EFO_0008317, EFO_0008591, EFO_0008596
Disease	total lipids in very large HDL measurement	PLTP COBLL1 APOB CMIP	1.95e-03	66	236	4	EFO_0022312
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	PLCB3 PLTP DNAH10 COBLL1 APOB PPP2R3A CMIP	2.04e-03	220	236	7	EFO_0004529, EFO_0008317
Disease	total lipids in small VLDL	PLTP DNAH10 COBLL1 APOB	2.06e-03	67	236	4	EFO_0022148
Disease	myocardial infarction	ATXN2 KALRN OAS3 APOB GOSR2 PPP2R3A UNC5C GPSM1 PDZD2	2.15e-03	350	236	9	EFO_0000612
Disease	Hepatocellular carcinoma	APC CASP8	2.21e-03	9	236	2	cv:C2239176
Disease	HEPATOCELLULAR CARCINOMA	APC CASP8	2.21e-03	9	236	2	114550
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	PLCB3 PLTP DNAH10 COBLL1 APOB CMIP	2.25e-03	166	236	6	EFO_0004530, EFO_0004611
Disease	congenital heart disease (implicated_via_orthology)	KMT2A CHD6 PDSS2 USP17L10	2.30e-03	69	236	4	DOID:1682 (implicated_via_orthology)
Disease	cholesterol in very large HDL measurement	PLTP COBLL1 APOB CMIP	2.30e-03	69	236	4	EFO_0022229
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	PELI3 ATXN2 PLCB3 PLTP DNAH10 COBLL1 APOB CMIP	2.49e-03	291	236	8	EFO_0008317, EFO_0020946
Disease	carbohydrate intake measurement	CYP1A2 ATXN2 MAPKAPK5	2.52e-03	34	236	3	EFO_0010811
Disease	high density lipoprotein particle size measurement	PLCB3 PLTP DNAH10 COBLL1 APOB CMIP	2.54e-03	170	236	6	EFO_0008592
Disease	very low density lipoprotein cholesterol measurement, phospholipid measurement	PLCB3 PLTP DNAH10 COBLL1 APOB PPP2R3A CMIP	2.56e-03	229	236	7	EFO_0004639, EFO_0008317
Disease	Liver carcinoma	CYLD CYP1A2 UROC1 FBP1 CCNA1 KMT2A KIFC1 APC CASP8 MED1 SLC26A6	2.73e-03	507	236	11	C2239176
Disease	abdominal aortic aneurysm (is_marker_for)	MYH11 POSTN	2.75e-03	10	236	2	DOID:7693 (is_marker_for)
Disease	cancer antigen 125 measurement	MUC16 MSLNL	2.75e-03	10	236	2	EFO_0010603
Disease	Leukemia, Myelocytic, Acute	MYH11 TRIO KMT2A FOXO1 CBL EP300	2.77e-03	173	236	6	C0023467
Disease	phospholipids in large HDL measurement	PLTP COBLL1 APOB CMIP	2.82e-03	73	236	4	EFO_0022190
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	ATXN2 PLCB3 COBLL1 APOB CMIP	2.94e-03	121	236	5	EFO_0008595, EFO_0020943
Disease	total lipids in large HDL	PLTP COBLL1 APOB CMIP	2.96e-03	74	236	4	EFO_0022189
Disease	free cholesterol to total lipids in large LDL percentage	PLTP COBLL1 APOB CMIP	2.96e-03	74	236	4	EFO_0022280
Disease	Abnormality of refraction	CDK12 ASAP1 SNAP91 GLI3 AKAP6 MROH9 TSHZ3 PCBP3 PCLO PCDHA5 MON1A TDRD7 FRY	3.18e-03	673	236	13	HP_0000539
Disease	Shortened QT interval	KCNH2 CACNA1C	3.34e-03	11	236	2	C0151879
Disease	hepatocyte growth factor-like protein measurement	BSN CCDC71 SLC26A6	3.47e-03	38	236	3	EFO_0008154
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	ATXN2 PLCB3 PLTP DNAH10 COBLL1 APOB CMIP	3.55e-03	243	236	7	EFO_0004612, EFO_0020944
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	ATXN2 PLCB3 COBLL1 APOB CMIP	3.62e-03	127	236	5	EFO_0008595, EFO_0020947
Disease	glucose measurement	SESN1 KL SNAP91 ATXN2 GLI3 BSN COBLL1 EDEM3 GPSM1	3.70e-03	380	236	9	EFO_0004468
Disease	free cholesterol in large HDL measurement	PLTP COBLL1 APOB CMIP	3.75e-03	79	236	4	EFO_0022157
Disease	cholesteryl ester measurement, high density lipoprotein cholesterol measurement	ATXN2 PLCB3 PLTP DNAH10 COBLL1 APOB CMIP GABBR1	3.80e-03	312	236	8	EFO_0004612, EFO_0010351
Disease	Moderate albuminuria	CYP1A2 CAMTA1 PDSS2 FAM171B	3.92e-03	80	236	4	HP_0012594

Protein segments in the cluster

Peptide	Gene	Start	Entry
MAVIATASLLFPQSS	ABCA5	281	Q8WWZ7
IPMFSNLASDEQDSV	PPP2R1A	206	P30153
APLADQNISVFMLST	CASTOR3	116	Q8NAP1
LMPQDNFTLTASSLE	ERV3-1	311	Q14264
TKTVLSNNLSPFAMD	EP300	276	Q09472
ASVSLQNSLDAPMED	EPB42	606	P16452
NESEMFDVPLTSLTI	EPG5	76	Q9HCE0
METVISSDSSPAVEN	PRKAG1	1	P54619
QEENLSVPFEMTTSE	BDP1	1956	A6H8Y1
TLEASSTPADMQNIL	CDK12	1196	Q9NYV4
SPSTTLEQMDFSAID	CAMTA1	576	Q9Y6Y1
SFDQPATIQTAMAIL	CCDC187	361	A0A096LP49
FKEENPMETSVSANT	CAGE1	161	Q8TC20
NPTVSLQEFLMAEQS	AQP12A	81	Q8IXF9
PQSFSAITLSNTEMN	APLF	271	Q8IW19
SPVMENNFVDLTEDT	BRD7	621	Q9NPI1
ASMNTTTILTFVPNE	ADGRG4	666	Q8IZF6
EMVSAVSQLTDSPDT	AKAP12	1001	Q02952
TLMSTDLLANSSDPD	CREBRF	26	Q8IUR6
EMETQSSDFPPSLTQ	BAZ2A	396	Q9UIF9
PSSLMSEIADLTFNT	EPN3	36	Q9H201
MILSDATQPLESQNF	AASS	426	Q9UDR5
SSIPEQLISNEMPFD	BNC1	516	Q01954
TATFLPSEDQVLMSS	ALPK3	1096	Q96L96
VDMALTSPLQDDSIN	CMIP	186	Q8IY22
FAQEQIAPLVSTMDE	ACADSB	71	P45954
SLNNARDTSAMDTLP	ADGRL2	1211	O95490
TMDEIENFSLTVNPL	DOP1A	1061	Q5JWR5
MNPTDIADTTLDESI	CCR4	1	P51679
QTSTPAEQDLEMASE	ANKRD36B	726	Q8N2N9
IPQMADTLFERATNS	SNAP91	56	O60641
DLTQAPSSLMETLEQ	SNAP91	266	O60641
LEEVMEQLNNSFPSS	DMD	3656	P11532
NPTVSLQEFLMAEES	AQP12B	81	A6NM10
MVASPAQTLNDTLDD	ANKRD17	1011	O75179
MNSELSVLANFSQPE	CD86	126	P42081
SDSMTFNLNSAPVVL	PDSS2	306	Q86YH6
SMLDFENQTLDPAIV	CAPRIN1	376	Q14444
LPLSENDQSFEVTMT	DMTF1	76	Q9Y222
MRQSSLTFQSSDPEQ	COBLL1	1066	Q53SF7
LTFQSSDPEQMRQSL	COBLL1	1071	Q53SF7
DLDNTELPFFTLEMS	ASTN2	136	O75129
EASLMSNLPLTSEAS	ASXL3	691	Q9C0F0
LLTEDDPQSQHMTLS	CKAP2	131	Q8WWK9
EMNDLPDTQVFICTS	NT5C	86	Q8TCD5
GSDQPDSEMTFDTNI	RUBCNL	246	Q9H714
PEQDTMTFSDGLTLN	RARG	281	P13631
MALSQSVPFSATELL	CYP1A2	1	P05177
DAFMTPSASLQQITA	EDC4	596	Q6P2E9
DQLSSDITPNAMDTE	INTS6	721	Q9UL03
TMDAELEFAIQPNTT	RDX	11	P35241
MLSLFSIPENSSESQ	DPH5	266	Q9H2P9
SLDPQMDNLFSVSST	FAT1	3581	Q14517
EETSQLTLSDFSPME	FHDC1	691	Q9C0D6
PQSMSNTLDDISVTS	MUC16	4801	Q8WXI7
TTSAPNMNITSDESL	MUC16	9486	Q8WXI7
PAQSTMSLDISDEVV	MUC16	9631	Q8WXI7
NDNQPSMTVIFLSAD	DCHS1	356	Q96JQ0
MSPENQSSVSEFLLL	OR1J2	1	Q8NGS2
TLPSKETAFLNTTQM	KANSL1L	586	A0AUZ9
DHSFDLQTMIRTSPN	GLI3	301	P10071
EQSSMSIEFGQESPE	MAP1B	1641	P46821
SIEFGQESPEQSLAM	MAP1B	1646	P46821
STEALDNVLPSAQLM	MAPKAPK5	306	Q8IW41
LQFPEINLMNVSETS	EYS	96	Q5T1H1
LANTEDPTEMASLDS	FAM174C	106	Q9BVV8
SMTASPQTEEFFDLI	GPSM1	541	Q86YR5
SLVFMALTDPSTQLQ	MMS19	446	Q96T76
PVTMILSSQQDAAFA	GABBR1	821	Q9UBS5
ELSFTMPQIQDQTPS	HIF1A	486	Q16665
LQPSSTSESMDQLLN	ATXN2	806	Q99700
DNEGSSSDTAPLFQM	EDEM3	736	Q9BZQ6
PTLTLDSLSQVSQFM	KCNH2	1101	Q12809
SQEAPFMVITLASDA	BSN	1551	Q9UPA5
LPSSASDMSLQTEEQ	BSN	2531	Q9UPA5
MFVNISPLEENVSES	KIFC1	636	Q9BW19
MEFSISALSIQEPSN	C1orf198	131	Q9H425
TASAFDVVMLSPNEE	FBXW8	316	Q8N3Y1
DMSLPDLDSSLASIQ	HSF1	426	Q00613
LMIAPVSTDNTFAVS	PCLO	3986	Q9Y6V0
TSSELDFQPQQELML	PLTP	76	P55058
PASDQEMNSVLAELS	PLXNB1	2061	O43157
LLSDPSTIEASNFQM	PNLIPRP1	71	P54315
MSFSNQIPEDSDLGT	PCDHGB1	346	Q9Y5G3
SAKTEFNSLNLTPEM	PCDHGB1	756	Q9Y5G3
DSSQPSSLLEMSSQE	PDZD2	1661	O15018
QMLNSDSATDETIPD	FRYL	2506	O94915
SDTVEFQIMDPTGNS	FREM1	1716	Q5H8C1
FDNDPTQDEMSSSLL	KALRN	1846	O60229
QFLSSSPLRMTNNED	MRTFB	526	Q9ULH7
SPVSMLNDLITFDTT	DEFB125	91	Q8N687
TMDAELEFAIQPNTT	MSN	11	P26038
TNDSDTTIPMDESLQ	GOSR2	111	O14653
TTIPMDESLQFNSSL	GOSR2	116	O14653
IFNPSQESTADLSGM	LMNTD2	376	Q8IXW0
ISMDIDTFTSLNPLE	MSLNL	531	Q96KJ4
NMPNTSVVLDTDAEF	HEG1	641	Q9ULI3
MSPENQSSVSEFLLL	OR1J1	1	Q8NGS3
DMSFTTSIVPQLLAN	OR2C3	71	Q8N628
ITNMLSSDVAQLSDP	PABIR1	221	Q96E09
DVNDNTPEMAITTLF	PCDHA5	341	Q9Y5H7
NESMILAVNSSFVDP	MROH9	41	Q5TGP6
VLMDEAPSNLSQAST	HUWE1	2381	Q7Z6Z7
QSLTMNPLENVSSDD	PPP2R3A	396	Q06190
NPLENVSSDDLMETL	PPP2R3A	401	Q06190
FEEDIINSMSNSPAT	PCBP3	111	P57721
QSSFVTSPAADNIEM	OCIAD1	141	Q9NX40
QDTAMETFNSPSLSL	PRICKLE3	581	O43900
EALDLSTDMTQPLSA	PLCB3	311	Q01970
MADQAPFDTDVNTLT	FBP1	1	P09467
PTDMRQISQDFSELS	MON1A	181	Q86VX9
KPSTMFVSSTEELNQ	CCSER2	126	Q9H7U1
QSMTLSSEVQIPDFD	APOB	1056	P04114
LLVFNPMSQDLSATE	CCDC71	31	Q8IV32
MSNLSLLEESEDFPQ	FOXO1	71	Q12778
PSMNAEENSRISITF	CACNA1C	1361	Q13936
NVPSVFLMTDSQVAE	DNAH17	2851	Q9UFH2
EIQESSPNMVCLDFT	DTX3L	266	Q8TDB6
TATDTVDVAMPLNFT	GGH	151	Q92820
FENSVNMLPSSTEVS	CENPC	186	Q03188
SQMSRTSESLENEPE	CHD6	1646	Q8TD26
SMNDQEEFISSCSLP	CEP63	641	Q96MT8
LGNLEQFSMESPSAS	CRTC2	556	Q53ET0
SMDIREFQLPSSQIS	BPI	86	P17213
SPESTVMLLEAQAAT	DSP	2041	P15924
LLDFNTVSPMLVDSS	CCNA1	176	P78396
TLVSMQDFTDLIAQP	DNAH7	376	Q8WXX0
QPSDDSTVSSFLDMN	DNAH7	866	Q8WXX0
PNTVFADSNIDSVMA	F11	206	P03951
VTPMDAATASLLNVF	APCDD1	371	Q8J025
MPDQISVSEFIAETT	ASAP1	21	Q9ULH1
MTISDSPREQDSESQ	CASP8	206	Q14790
MSSPDFDNQTLAVLR	MCRS1	336	Q96EZ8
QECMSQPELLTSLFD	FOXR2	296	Q6PJQ5
SINAEPSENLQSLME	KIF4B	376	Q2VIQ3
MKNNLSSILPDFTES	KL	341	Q9UEF7
SDVVSNMTLINFTPS	KMT2A	3246	Q03164
TDTSALSSINPDEIM	DBR1	416	Q9UK59
ATASPQLSSEIENLM	CBL	851	P22681
IPSFVIQMDFSADSS	EML5	1821	Q05BV3
TMDAELEFAIQPNTT	EZR	11	P15311
PESLTEQVAMTLASA	E4F1	716	Q66K89
GEDPQFDQVISSMSS	FRY	101	Q5TBA9
PTFTSTEAAIQSMLE	FRY	2896	Q5TBA9
PLMDFISKNQSNESS	HORMAD1	126	Q86X24
FLSDIPSSQILQEEM	ETNK1	276	Q9HBU6
SPLSLSAQSVMEELN	CYLD	436	Q9NQC7
AEIPLQDTTAEAFTM	BTBD9	76	Q96Q07
ESDSMLVANLQPVFT	DNAH10	311	Q8IVF4
MENLTFDPFSIKSSQ	DNAH10	516	Q8IVF4
LSNTSPEFQEMSLLE	SACM1L	146	Q9NTJ5
NLDEIQMSSPTFLRA	EIF4G3	1451	O43432
TLNEAVVMTPFSSEL	FAM171B	636	Q6P995
NPIFDVNMTADTLDT	MED1	721	Q15648
TSQTMLDQSVDFDVL	OAS3	876	Q9Y6K5
ITSSFPQLMSNVDAA	MMP20	336	O60882
MLSSFVTQTQPISLA	OR10J6P	81	Q8NGY7
DMVVPSSDSSDQLAI	KIF13A	1611	Q9H1H9
STDMNTEVDALDPSI	FOXN4	411	Q96NZ1
ASPNAQMDDVIDTLT	RTL6	16	Q6ICC9
LSTEAFIPQTIEQMS	SLITRK4	681	Q8IW52
AQTTPLAAMEALSTE	SELPLG	251	Q14242
STESVPQFTDVEMQS	SERTM2	71	A0A1B0GWG4
QDIDFATTATPTQMK	TRNT1	76	Q96Q11
MPVNSAENVSVSDSF	SESN1	256	Q9Y6P5
DAQPMTSLDTAILAQ	STK40	416	Q8N2I9
NSALPTSSQDEELME	SRRM2	1226	Q9UQ35
LNDSSEMDPSTQISL	TBC1D31	1011	Q96DN5
ADIVTFPEINLMNES	SYNE1	4581	Q8NF91
MSLATLTPDENSLDF	SYNRG	1216	Q9UMZ2
LTPDENSLDFSSCML	SYNRG	1221	Q9UMZ2
SMPTSEETLFLPENQ	NBR1	196	Q14596
EPSTTIFTQLATMAA	RHOT2	561	Q8IXI1
KNLSASFPMEESSIN	RGPD2	1611	P0DJD1
QDESNMSVLDIPSAT	TAF1	1666	P21675
SVTESLAPQALNDSM	SLC26A6	156	Q9BXS9
FLTTASMVSILPQDS	SCRN3	276	Q0VDG4
DPQTETLSAMDVSEF	MTF1	706	Q14872
STENMIDFVVTDTSP	PELI3	156	Q8N2H9
LMESVNFSPANLSST	HAUS1	76	Q96CS2
FPANSTAMVDLTNSL	PHF12	716	Q96QT6
ASIFNTLSDIPSQME	SGSM3	331	Q96HU1
SNFVPSDFMEELLTL	SPATA31D4	366	Q6ZUB0
QVFATENAIPDSMTE	STARD9	1606	Q9P2P6
IAESANTFMEDITVP	TDRD7	441	Q8NHU6
DNLSTVSMFLNTLTP	ST7	46	Q9NRC1
DQPSIFEVVAQDSLM	PEX12	16	O00623
EMQSPSTREISDLAF	PROB1	561	E7EW31
SDLSSNLEERMQSPQ	NOL4	236	O94818
SSENMSEESVVLSFP	SERPINB12	286	Q96P63
MDFSIRISNITPADA	SIRPB1	101	Q5TFQ8
ISSSEMTNPSDTLNI	AKAP6	1831	Q13023
LQSDSSIVTMAFPTL	ADGRF5	891	Q8IZF2
NTLASTDMEISSAEP	CCDC54	181	Q8NEL0
AQLSSQKMESFSAVP	ANKHD1	2011	Q8IWZ3
SLPLTENFSLQTDMT	APC	171	P25054
NPANIGFSTLTMESD	CLTC	21	Q00610
NPANIGFSTLTMESD	CLTCL1	21	P53675
ISNSEDFKNTIPMVT	CLCA4	276	Q14CN2
TTQDSTDLVDNMSPE	CLCN1	786	P35523
FLATEVEAFSPSQMS	CNNM2	631	Q9H8M5
MDPLNDNVTSLLNAS	MYH11	596	P35749
PMRETLNVDSIFSES	USP53	586	Q70EK8
EMAASSSFQPTLNSL	RECQL5	131	O94762
AQNSELSMDSVVPFD	TIMELESS	571	Q9UNS1
SQSEDELTPFDMSIQ	XRCC6	51	P12956
SNFVPSDFMEELLTL	SPATA31D3	366	P0C874
TEFDAAQVLQMLPDT	TGFBRAP1	746	Q8WUH2
PDEDSTNVAFTISML	AVPR1B	311	P47901
MAAPDLSTNLQEEAT	TRIM11	1	Q96F44
SELSSPGQSELTNMD	ZXDC	496	Q2QGD7
DPSMLSQAQSATEVE	TRMT61B	121	Q9BVS5
VTLEASFTPDSQFIM	WDR82	241	Q6UXN9
SSDIPLDNSSTVNME	ZFHX2	301	Q9C0A1
LSLPSQSEQAVMSLS	RINT1	631	Q6NUQ1
SMVQEENSTFNALPA	PROM2	346	Q8N271
PVQLSFTEAQSLMAS	UROC1	356	Q96N76
DTIFEMQLASQISES	RYR3	4091	Q15413
ASLASNLEISQSPTM	TICAM1	201	Q8IUC6
QFIAATPTSLMEAQA	TTBK2	646	Q6IQ55
ATFIQIPSDFTMNDT	PRLR	221	P16471
LAEFNSTPAVFTMIT	NRDC	781	O43847
SNFVTADLTAEPEMI	STAM	261	Q92783
EPSQEQDILTSMEAS	TECPR2	676	O15040
NVSLLNLAAMEPTDS	TSKS	81	Q9UJT2
LSFDTSKMNQPDSIV	RAB11FIP2	276	Q7L804
MSVLDETEVANSSAP	SAFB2	131	Q14151
ALEMESSEPTAQDTT	TMEM275	111	A0A0U1RQS6
LSTFVSEQQMESQEP	TNFRSF10A	306	O00220
PDNSESVMTVANFLS	TAS1R2	141	Q8TE23
VSFMSNSPLRENALS	TSHZ3	831	Q63HK5
SPSAENMNEASSLLS	PLEKHA3	146	Q9HB20
EVQPSDSFLMVETTA	ZNFX1	496	Q9P2E3
MLTPASQNDLSDFRS	TPRN	691	Q4KMQ1
NITDEIMSQFPSSKV	TGFB1I1	106	O43294
KDSETSFVPTNMAVN	C9orf78	206	Q9NZ63
SESFSSLLKNMIQPD	WEE2	456	P0C1S8
DLSFQAASQIMSAPV	UGGT2	311	Q9NYU1
MATASSQVLIPDINF	MID2	361	Q9UJV3
LAPVNNAFSDDTLSM	POSTN	406	Q15063
AISLFPQMSEIETSQ	SFXN5	306	Q8TD22
MAFLDVQSSSTPQSL	nan	11	Q6ZS46
NLISDSPQAMASLAS	TRIM66	716	O15016
QDDLSEFTSKLSPQM	UNC5C	491	O95185
PNGSFSNAEMSELSV	ZC3H14	576	Q6PJT7
MENQEFLSSSAPSEV	THEGL	1	P0DJG4
SEMSQNSSLSESLPI	HIVEP1	1711	P15822
ETDFMVVQQPSLASD	SOCS6	21	O14544
FLTNLPEETNELMLS	SNRPA	211	P09012
SDASPMSINEVILSA	THAP4	321	Q8WY91
PFLTNLSESEMFASE	TIPIN	176	Q9BVW5
FPELSELSVSQLTDM	VPS37A	231	Q8NEZ2
DNSLLSSSSPIDEME	TRIO	1946	O75962
LLNLSSTTPTDQESM	USP17L10	486	C9JJH3
ATFPSVSDSLLQVAM	TTC31	131	Q49AM3
ASPDQLISSMLDQVD	ZNF541	1021	Q9H0D2
APMENVTIFISTSSE	VWA5B1	136	Q5TIE3
IEQMLSLPAEVSSDN	LONRF3	6	Q496Y0
VLSESPSQDSLDAFM	SLC4A1AP	526	Q9BWU0
SNVDFLETPELTSTM	NECAB1	326	Q8N987